arginine has been researched along with Cardiovascular Diseases in 513 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.39) | 18.7374 |
| 1990's | 29 (5.65) | 18.2507 |
| 2000's | 199 (38.79) | 29.6817 |
| 2010's | 243 (47.37) | 24.3611 |
| 2020's | 40 (7.80) | 2.80 |
| Authors | Studies |
|---|---|
| Figueroa, A; Flores-Ramírez, AG; Garay-Sevilla, ME; Maharaj, A; Tovar-Villegas, VI | 1 |
| Akins, JD; Brothers, RM; Campbell, JC; Martin, ZT; Olvera, G; Richey, RE | 1 |
| Farkas, R; Karvaly, GB; Kovács, K; Vásárhelyi, B | 1 |
| Brunengraber, H; Cushman, M; Feldman, HI; Gutiérrez, OM; Hostetter, TH; Ix, JH; Katz, R; Kimmel, PL; Rhee, EP; Sapa, H; Sarnak, MJ; Schelling, JR; Schrauben, SJ; Seegmiller, JC; Shlipak, MG; Vasan, RS | 1 |
| Bonnitcha, P; Fitzpatrick, M; Ireland, A; Koay, YC; Nguyen, VL; O'Sullivan, J; Sullivan, D | 1 |
| Alonso-Gómez, Á; Arós, F; Atzeni, A; Babio, N; Clish, CB; Corella, D; Dennis, C; Estruch, R; Fiol, M; Fitó, M; Gómez-Gracia, E; Goni, L; Guasch-Ferré, M; Hu, FB; Lapetra, J; Li, J; Liang, L; Martínez-González, MA; Razquin, C; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wittenbecher, C | 1 |
| Hidayat, R; Hustrini, NM; Pradwipa, RY; Shatri, H | 1 |
| Clish, CB; Gerszten, RE; Gonzalez Izundegui, D; Larson, MG; Miller, PE; Mitchell, GF; Nayor, M; Shah, RV; Vasan, RS; Walker, ME | 1 |
| Andraweera, PH; Arstall, MA; Kosmider, L; Lassi, ZS; Tiong, P | 1 |
| Albrecht, MH; Alizadeh, LS; Bernatz, S; Booz, C; D'Angelo, T; Eichler, K; Gruber-Rouh, T; Gruenewald, LD; Hardt, SE; Koch, V; Leistner, DM; Mahmoudi, S; Martin, SS; März, W; Nour-Eldin, NA; Scholtz, JE; Vogl, TJ; Yel, I | 1 |
| Demirbas, N; Eryavuz Onmaz, D; Kutlu, R; Onmaz, M; Unlu, A | 1 |
| Chen, G; Chen, M; Deng, Y; Fan, C; Hu, M; Lai, X; Li, C; Liu, X; Song, Y; Sun, J; Wang, S; Wang, Y; Xu, F | 1 |
| Feng, X; Hou, C; Li, G; Li, W; Li, Y; Liu, Y; Tan, J; Tang, Q; Xu, J; Xu, W; Xu, Z; Yang, D; Yang, M; Zeng, W; Zhang, X; Zhou, J; Zhu, C | 1 |
| Chang, Z; Cheng, Y; Huang, Q; Jia, F; Liao, P; Liu, K; Liu, X; Liu, Y; Lu, Y; Ma, D; Pu, C; Xu, L; Yan, Q; Zhang, H | 1 |
| Anderson, AH; Bhat, Z; Brown, J; Brunengraber, H; Charleston, J; Chen, J; Feldman, HI; He, J; Hostetter, TH; Hsu, CY; Ix, JH; Kimmel, PL; Mehta, R; Rao, P; Sapa, H; Schelling, JR; Schrauben, SJ; Seegmiller, JC; Shafi, T; Shlipak, MG; Townsend, R; Vasan, RS; Xie, D; Zhang, X | 1 |
| Au, AYM; Bahadory, F; Endre, ZH; Erlich, J; Guiney, H; Horvath, AR; Mantik, K; Poulton, R; Stathakis, P; Walker, R | 1 |
| Almeida, CC; Baião, DDS; da Silva, DVT; Paschoalin, VMF | 1 |
| Diniz, MS; Falcão-Pires, I; Hiden, U; Oliveira, PJ; Pereira, SP; Sobrevia, L | 1 |
| Bertoldi, JMCRJ; Fernandes-Santos, C; Gomes, JLP; Kindlovits, R; Medeiros, RF; Muniz, IC; Nóbrega, ACLD; Oliveira, EM; Pereira, JF; Rocha, HNM; Rocha, NG; Santos, MM | 1 |
| Baach, F; Böger, R; Choe, CU; Lezius, S; Meyer, B; Neu, A; Oh, J; Schwedhelm, E | 1 |
| Böger, R; Hannemann, J; Laing, A; Middleton, B; Schwedhelm, E; Skene, DJ | 1 |
| Bednarz-Misa, I; Bronowicka-Szydełko, A; Fleszar, MG; Gacka, M; Gamian, A; Kędzior, K; Krzystek-Korpacka, M; Masłowski, L; Wiśniewski, J; Witkiewicz, W | 1 |
| Atzler, D; Ayers, CR; de Lemos, JA; Gore, MO; Hackler, E; Khera, A; Lew, J; Lewis, A; Neeland, I; Omland, T; Rohatgi, A | 1 |
| Bode-Böger, SM; Jarzebska, N; Mangoni, AA; Martens-Lobenhoffer, J; Rodionov, RN | 1 |
| Hsu, CN; Lin, IC; Lo, MH; Lu, PC; Tain, YL | 1 |
| Hu, W; Liu, T; Ma, Q; Wang, W; Zhang, J | 1 |
| Citadin, CT; Clemons, GA; Couto E Silva, A; Frankel, A; Grames, MS; Lee, RH; Lien, CF; Lin, HW; Minagar, A; Possoit, HE; Wu, CY | 1 |
| Derkacz, A; Gać, P; Gocławska, K; Jurdziak, M; Mazur, G; Poręba, M; Poręba, R; Szuba, A; Trzmielewska, E | 1 |
| Castellino, P; Fatuzzo, P; Gaudio, A; Granata, A; Lentini, P; Malatino, L; Rapisarda, F; Sessa, C; Xourafa, A; Zanoli, L | 1 |
| Doroszko, A; Gajecki, D; Gawrys, J; Szahidewicz-Krupska, E | 1 |
| Al-Hamashi, AA; Diaz, K; Huang, R | 1 |
| Ashokachakkaravarthy, K; Mohan Raj, PS; Parameswaran, S; Priyadarshini, G; Priyadarssini, M; Rajappa, M; Revathy, G; Satheesh, S | 1 |
| Ochoa-Martínez, ÁC; Orta-García, ST; Pérez-Maldonado, IN; Varela-Silva, JA | 1 |
| Du, Q; Gao, J; Jin, Y; Lu, R; Yan, Y; Yu, C; Zou, Y | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Cai, R; Chen, C; Gao, X; Ji, Y; Li, H; Meng, D; Wang, L; Wu, X; Yan, J | 1 |
| Dragičević, M; Košuta, I; Kruezi, E; Lovrenčić, MV; Mrzljak, A | 1 |
| Bakker, SJL; Bollenbach, A; Post, A; Tsikas, D | 1 |
| Charkiewicz, AE; Garley, M; Jabłońska, E; Maślach, D; Nowak, K; Omeljaniuk, WJ; Ratajczak-Wrona, W | 1 |
| Castro-Diehl, C; Ehrbar, R; Obas, V; Oh, A; Vasan, RS; Xanthakis, V | 1 |
| Amarasekera, N; Manoharan, S; Sarker, P | 1 |
| Beltran-Alvarez, P; Birkett, S; Carroll, S; Guinn, BA; Ingle, L; Marsden, AJ; Riley, DRJ; Rodriguez-Barucg, Q; Sathyapalan, T | 1 |
| Dai, Z; Fan, Y; Xiang, S; Zhang, H | 1 |
| Enko, D; März, W; Meinitzer, A; Pilz, S; Tomaschitz, A; Zelzer, S | 1 |
| Arós, F; Clish, CB; Corella, D; Estruch, R; Fitó, M; Gómez-Gracia, E; Guasch-Ferré, M; Hruby, A; Hu, FB; Lapetra, J; Liang, L; Martínez-González, MA; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wang, DD; Yu, E | 1 |
| Berge, RK; Gaardbo, JC; Gerstoft, J; Hove-Skovsgaard, M; Kolte, L; Nielsen, SD; Seljeflot, I; Svardal, A; Trøseid, M; Ullum, H; Winding, K | 1 |
| Böger, RH; de Las Heras Gala, T; Dressel, A; Fliser, D; Heier, M; Jennings, RT; Kleber, ME; Koenig, W; Landmesser, U; Laufs, U; Lehmann, M; Lepper, PM; Lüscher, TF; März, W; Meinitzer, A; Meisinger, C; Petrakis, I; Ritsch, A; Rohrer, L; Scharnagl, H; Schwedhelm, E; Speer, T; Thorand, B; Triem, S; von Eckardstein, A; Wagenpfeil, S; Zewinger, S | 1 |
| Arya, S; Connelly, PW; Hanley, AJ; Retnakaran, R; Sermer, M; Ye, C; Zinman, B | 1 |
| Hsu, CN; Tain, YL | 1 |
| Alshahawey, M; Elsaid, TW; Sabri, NA; Shahin, SM | 1 |
| Singh, SA; Srinivasan, K; Venkatesh, R | 1 |
| Elliot, DJ; Hulin, JA; Lewis, BC; Mangoni, AA; McEvoy, M; Tommasi, S | 1 |
| Choi, HR; Jeon, DH; Kim, HC; Lee, SW; Yeom, H; Youm, Y | 1 |
| Hansen, TW; Jacobsen, PK; Parving, HH; Persson, F; Reinhard, H; Rossing, P; Teerlink, T; von Scholten, BJ; Zobel, EH | 1 |
| Javn, SB; Loganathan, S; Mala, K; Ramachandran, S; Sundari, M; Thomas, S | 1 |
| Baker, G; Gyenes, G; Hess, S; Le Melledo, JM; Newman, S; Tsuyuki, R | 1 |
| Almendarez-Reyna, CI; Ochoa-Martínez, ÁC; Orta-García, ST; Pérez-Maldonado, IN; Ruíz-Vera, T | 1 |
| Atzler, D; Böger, RH; Huisman, HW; Kruger, R; Malan, L; Malan, NT; Mels, CMC; Schutte, AE; Schwedhelm, E; Smith, W; van Rooyen, JM | 1 |
| El-Banna, M; El-Naggar, ME; Hussein, J; Razik, TA | 1 |
| Chen, XP; Hu, XL; Li, MP; Song, PY; Tang, J | 1 |
| Chang, J; Chen, JY; Hong, FF; Wang, XF; Yang, MW; Yang, SL; Ye, ZX; Zhong, HH | 1 |
| Bode-Böger, SM; Emrich, IE; Fliser, D; Heine, GH; Martens-Lobenhoffer, J; Wagenpfeil, S; Zawada, AM | 1 |
| Cynober, L; Forbes, A; Osowska, S; Papadia, C | 1 |
| Cardona-Lozano, ED; Carrizales-Yáñez, L; Ochoa-Martínez, ÁC; Pérez-Maldonado, IN | 1 |
| Kolpakov, IY; Kondrashova, VH; Kryzhanivska, VV; Leonovich, OS; Stepanova, YI; Vdovenko, VY; Zygalo, VM | 1 |
| Feng, S; Li, H; Lu, X; Wang, F; Wang, S; Xiong, R | 1 |
| Aydogdu, A; Azal, O; Basaran, Y; Demir, O; Demirci, I; Dinc, M; Haymana, C; Meric, C; Sonmez, A; Torun, D; Yesildal, F | 1 |
| Kronenberg, F | 1 |
| Batista, MC; Mayer, S; Quinto, BMR; Triches, CB; Zanella, MT | 1 |
| Aukrust, P; Gaardbo, JC; Gelpi, M; Gerstoft, J; Hoel, H; Holm, K; Hov, JR; Hove-Skovsgaard, M; Kummen, M; Nielsen, SD; Nwosu, F; Rudi, K; Seljeflot, I; Trøseid, M; Ueland, PM; Ullum, H; Valeur, J | 1 |
| Chandrasekharan, UM; Elaine Husni, M; Hazen, SL; Wang, S; Wang, Z; Wilson Tang, WH; Wu, Y | 1 |
| Briggs, WTE; Castro, C; FitzGerald, GA; Griffin, JL; Karlson, EW; Lahens, NF; Li, X; Malik, D; Meng, H; Rhoades, SD; Ricciotti, E; Sparks, JA; Tang, SY; Weljie, AM; West, JA | 1 |
| Chen, S; Cui, Y; Mu, G; Xiang, Q; Xie, Q; Zhang, Z; Zhao, X; Zhou, S | 1 |
| Brodmann, M; Gary, T; Hackl, G; Hafner, F; Jud, P; Meinitzer, A; Seinost, G; Verheyen, N | 2 |
| Hahn, A; Ströhle, A; von Bibra, H | 1 |
| Brzeziński, M; Czumaj, A; Śledzińska, M; Śledziński, T; Szlagatys-Sidorkiewicz, A; Słomińska, E | 1 |
| Kulwas, A; Rość, D; Wieczór, AM; Wieczór, R | 1 |
| Beidler, J; Figueroa, A; Hong, MY; Hooshmand, S; Kern, M | 1 |
| Gouya, G; Litschauer, B; Ohrenberger, G; Sheikh Rezaei, S; Weisshaar, S; Wolzt, M | 1 |
| Nakaya, I; Nakayama, K; Nakayama, M; Soma, J; Tezuka, Y; Yahata, M | 1 |
| Almendarez-Reyna, CI; Carrizales-Yáñez, L; Ochoa-Martínez, ÁC; Pérez-Maldonado, IN; Ruiz-Vera, T; Zarazúa, S | 1 |
| Aleksandrowicz-Wrona, E; Dębska-Ślizień, A; Heleniak, Z; Lichodziejewska-Niemierko, M; Małgorzewicz, S; Rutkowski, R | 1 |
| Fujisawa, Y; Gohda, T; Horikoshi, S; Kobayashi, T; Nishiyama, A; Shiota, S; Sugaya, T; Suzuki, Y; Takahashi, K; Ueda, S | 1 |
| Fayh, APT; Krause, M; Rocha, IMGD; Rodrigues-Krause, J; Umpierre, D | 1 |
| Fromm, MF; König, J; Maas, R; Taghikhani, E | 1 |
| Bakker, SJL; Bollenbach, A; de Borst, MH; Frenay, AR; Kayacelebi, AA; Minović, I; Navis, G; Said, MY; Tsikas, D; van den Berg, E; van Goor, H; van Londen, M | 1 |
| Dimitroulas, T; Kitas, GD | 1 |
| Hartley, AV; Jin, J; Lu, T; Martin, M | 1 |
| Baamonde-Laborda, E; Gonzalez-Cabrera, F; Oliva-Damaso, E; Oliva-Damaso, N; Payan, J; Rodriguez-Esparragon, F; Rodriguez-Perez, JC; Santana-Estupiñan, R | 1 |
| Alizadeh-Navaei, R; Niksolat, F; Rafiei, A; Samimi, Z; Taghadosi, M; Zafari, P; Zarifian, A | 1 |
| Auge, D; Chafai, A; Fromm, MF; Gessner, A; Maas, R; Mieth, M; Müller, F | 1 |
| Jung, C; Pernow, J | 1 |
| Linz, TH; Lunte, SM | 1 |
| Böger, RH; Glyn, MC; Huisman, HW; Lüneburg, N; Mels, CM; Schutte, AE; Schutte, R; Schwedhelm, E; Van Rooyen, JM | 1 |
| Bitla, AR; Reddy, VS; Sachan, A; Srinivas Rao, PV; Suchitra, MM; Suresh, V; Tejovathi, B | 1 |
| Bouras, G; Deftereos, S | 1 |
| Bouras, G; Chatzis, G; Cleman, MW; Deftereos, S; Giannopoulos, G; Stefanadis, C; Tousoulis, D; Tsounis, D | 1 |
| Barath, S; Blackwell, S; Blomberg, A; Bosson, J; Langrish, JP; Megson, IL; Mills, NL; Muala, A; Newby, DE; Pourazar, J; Sandström, T; Söderberg, S; Treweeke, A; Unosson, J | 1 |
| Bandinelli, S; D'Arrigo, G; Dattolo, P; Ferrucci, L; Maas, R; Michelassi, S; Mieth, M; Pizzarelli, F; Tripepi, G; Zoccali, C | 1 |
| Bogdanović, D; Cvetković, TP; Ignjatović, AM; Milošević, ZG; Pavlović, DD; Pavlović, RM; Stojanović, IR; Đorđević, VB; Đorđević, VM | 1 |
| Arefin, S; Carrero, JJ; Hammarqvist, F; Kublickiene, K; Näslund, E; Nordfors, L; Qureshi, AR; Rydén, M; Stenvinkel, P; Witasp, A | 1 |
| Cottin, Y; Guilland, JC; Lorin, J; Rochette, L; Vergely, C; Zeller, M | 1 |
| Dekker, JM; Engelen, L; Ferreira, I; Hanssen, NM; Huijberts, MS; Nijpels, G; Schalkwijk, CG; Scheijen, JL; Stehouwer, CD; van der Kallen, CJ; van Greevenbroek, MM | 1 |
| Cooke, JP; Erlanson, DA; Ghebremariam, YT; Lee, JC; Leiper, J; LePendu, P; Shah, NH; Slaviero, A | 1 |
| Ajisaka, R; Eto, M; Kumagai, H; Maeda, S; Miyaki, A; So, R; Tanaka, K | 1 |
| Micans, P | 1 |
| Brunini, TM; Figueredo, CM; Fischer, RG; Martins, MA; Mendes-Ribeiro, AC; Moss, MB; Pereira, NR; Siqueira, MA | 1 |
| Chang, SL; Chao, TF; Chen, SA; Hsieh, MH; Hu, YF; Lin, YJ; Lo, LW; Lu, TM; Tsao, HM; Tuan, TC | 1 |
| Boeger, RH; Hamer, M; Lambert, GW; Malan, L; Malan, NT; Reimann, M; Schlaich, MP; Ziemssen, T | 1 |
| Deloach, S; Huan, Y; Kapoor, S; Meyers, K; Ommen, E; Townsend, RR | 1 |
| Anderssohn, M; Atzler, D; Ayers, CR; Böger, RH; de Lemos, JA; Gore, MO; Grant, PJ; Khera, A; Lüneburg, N; McGuire, DK; Schwedhelm, E | 1 |
| Boehm, BO; Drechsler, C; Fahrleitner-Pammer, A; Hoffmann, MM; Huang, J; Kähönen, M; Kienreich, K; Kleber, ME; Koenig, W; Krane, V; Laaksonen, R; Lehtimäki, T; Lyytikäinen, LP; Mäkelä, KM; März, W; Meinitzer, A; Oksala, N; Pilz, S; Raitakari, OT; Raitoharju, E; Seppälä, I; Tomaschitz, A; Wanner, C | 1 |
| Aijälä, M; Bloigu, R; Kesäniemi, YA; Santaniemi, M; Ukkola, O | 1 |
| Hudson, CL; Ipp, H; Zemlin, AE | 1 |
| Ajjan, R; Anderssohn, M; Böger, RH; Grant, PJ; Lüneburg, N; McLachlan, S; Price, JF; Robertson, C; Schwedhelm, E; Strachan, MW; Williamson, RM | 1 |
| Bramlage, C; Konstantinides, S; Koziolek, MJ; Mueller, GA; Puls, M; Strauchmann, J; Wallbach, M | 1 |
| Chiarelli, F; Chiavaroli, V; de Giorgis, T; Diesse, L; Giannini, C; Marcovecchio, ML; Mohn, A | 1 |
| Ferrone, A; Franceschelli, S; Pesce, M; Riccioni, G; Speranza, L | 1 |
| Dimitroulas, T; Kitas, GD; Sandoo, A; Smith, JP | 1 |
| Abd El Dayem, SM; Battah, AA; El Bohy, Ael M; El-Shehaby, A | 1 |
| Baranyi, A; Kapfhammer, HP; Meinitzer, A; Putz-Bankuti, C; Rothenhäusler, HB; Stauber, R | 1 |
| Chyrchel, B; Chyrchel, M; Surdacki, A | 1 |
| Lundberg, JO; Montenegro, MF | 1 |
| Amaral, JH; Pinheiro, LC; Tanus-Santos, JE | 1 |
| Cooke, JP; Erlanson, DA; Ghebremariam, YT; Lee, JC; Leiper, JM; LePendu, P; Shah, NH; Slaviero, A | 1 |
| Öğünç, AV; Okur, HK; Öztürk, L; Pelin, Z; Yüksel, M | 1 |
| Ahmadi, Y; Badalzadeh, R; Faghfoori, Z; Ghavimi, H; Jabbarpour, M; Karami, H; Majidinia, M; Samadi, N; Shafiei-Irannejad, V; Yousefi, B | 1 |
| Bode-Böger, SM; Fliser, D; Kielstein, JT; Schepers, E; Speer, T | 1 |
| Drent, ML; Franken, AA; Heymans, MW; Koppeschaar, HP; van Bunderen, CC; van den Dries, CJ; van der Lely, AJ | 1 |
| Atzler, D; Böger, RH; Dörr, M; Friedrich, N; Kroemer, HK; Nauck, M; Schwedhelm, E; Völker, U; Völzke, H; Wallaschofski, H | 1 |
| Beckmann, B; Gutzki, FM; Jordan, J; Kayacelebi, AA; Tsikas, D | 1 |
| Atzler, D; Böger, RH; Friedrich, N; Ittermann, T; Nauck, M; Schwedhelm, E | 1 |
| Aukrust, P; Consoli, A; Davì, G; Di Fulvio, P; Formoso, G; Lattanzio, S; Liani, R; Santilli, F; Ueland, T; Vazzana, N | 1 |
| Abu el Maaty, MA; El-Maraghy, SA; Fahim, AT; Gad, MZ; Hamdy, MA | 1 |
| Chan, WP; Chirkov, YY; Horowitz, JD; Ngo, DT; Sverdlov, AL | 1 |
| Doerfer, J; Grulich-Henn, J; Grünert, SC; Holder, M; Krebs, A; Lichte, K; Schmidt-Trucksäss, A; Schwab, KO; Stier, B; Winkler, K; Wöhrl, J | 1 |
| Adesso, S; Autore, G; Marzocco, S; Pinto, A; Popolo, A | 1 |
| Balta, S; Erdem, K; Karakus, Y; Kurtoglu, E | 1 |
| Dimitroulas, T; Douglas, KM; Hodson, J; Kitas, GD; Sandoo, A; Smith, JP | 2 |
| Bilge, AK; Caliskan, Y; Deniz, G; Ozkok, A; Sariyar, M; Yildiz, A; Yilmaz, A; Yilmaz, BA | 1 |
| Gerstoft, J; Kvale, D; Manner, IW; Nielsen, SD; Os, I; Pedersen, KK; Seljeflot, I; Trøseid, M | 1 |
| Döner, U; Düngen, HD; Duvinage, A; Edelmann, F; Gaksch, M; Gelbrich, G; Kienreich, K; Kunde, J; März, W; Meinitzer, A; Pieske, B; Pilz, S; Schmidt, A; Stahrenberg, R; Tomaschitz, A; Wachter, R | 1 |
| Alpoim, PN; Dusse, LM; Mota, AP; Rios, DR; Sousa, LP | 1 |
| Ahles, A; Bünemann, M; Engelhardt, S; Rochais, F; Rodewald, F | 1 |
| Cao, H; Fan, Y; Hu, X; Li, J; Liu, B; Shao, Y; Wang, J; Yang, J; Zhang, Q | 1 |
| Chung, MY; Hsu, CP; Hsu, PF; Lin, SJ; Lu, TM | 1 |
| Ahmetaj-Shala, B; Al'Yamani, M; Armstrong, PC; Kirkby, NS; Knowles, R; Leiper, J; Mackenzie, L; Mazi, S; Mitchell, JA; Nüsing, RM; Tomlinson, JA; Tucker, AT; Wang, Z; Warner, TD | 1 |
| Cefle, A; Kir, HM; Sahin, T; Unlu, BÖ; Yilmazer, B | 1 |
| Eichelberger, B; Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S; Perkmann, T; Seidinger, D; Steiner, S | 1 |
| Aasarød, KI; Åsberg, A; Hov, GG; Sagen, E | 1 |
| Cetinkaya, H; Eyileten, T; Gok, M; Haymana, C; Karaman, M; Oguz, Y; Rizzo, M; Saglam, M; Sonmez, A; Toth, PP; Unal, HU; Vural, A; Yilmaz, MI | 1 |
| Kaneko, K; Kuroyanagi, Y; Takaya, J; Tanabe, Y | 1 |
| Kruszelnicka, O; Sulicka-Grodzicka, J; Surdacki, A; Wieczorek-Surdacka, E; Włoch, A | 1 |
| Akilli, H; Alibasic, H; Aribas, A; Gunduz, M; Kayrak, M; Taner, A; Tekinalp, M; Unlu, A; Yildirim, S | 1 |
| Bassareo, PP; Bassareo, V; Flore, G; Mercuro, G; Mussap, M | 1 |
| Chowdhury, R; Chowdhury, S; Di Angelantonio, E; Freitag, DF; Gobin, R; Laukkanen, JA; Mayr, M; Willeit, P | 1 |
| Berkowitz, SD; Costin', J; Curnutte, JT; Gibson, CM; Hoffman, M; Kaminskas, E; Kowey, PR; Krucoff, MW; Levy, JH; Mintz, PD; Reilly, PA; Sager, PT; Sarich, TC; Seltzer, JH; Singer, DE; Stockbridge, N; Weitz, JI | 1 |
| İn, E; Kaman, D; Özdemir, C; Sökücü, SN | 1 |
| Georgakis, MK; Latsios, G; Oikonomou, E; Papageorgiou, N; Papaioannou, S; Siasos, G; Tousoulis, D; Zaromitidou, M | 1 |
| Calhoun, D; Dudenbostel, T; Ellis, AC; Gower, B; Patterson, M | 1 |
| Cleary, PA; Gao, X; Genuth, S; Lachin, JM; Monnier, VM; Sell, DR; Sun, W | 1 |
| Isenovic, ER; Jovanovic, A; Obradovic, M; Panic, A; Radak, D; Sudar-Milovanovic, E; Zafirovic, S; Zaric, B | 1 |
| Leung, SW; Vanhoutte, PM; Zhao, Y | 1 |
| Kruszelnicka, O; Surdacki, A; Wieczorek-Surdacka, E | 1 |
| Ahmetaj-Shala, B; Al'Yamani, M; Armstrong, PC; Kirkby, NS; Knowles, R; Leiper, J; Mackenzie, LS; Mazi, S; Mitchell, JA; Nüsing, RM; Tomlinson, JA; Tucker, AT; Wang, Z; Warner, TD | 1 |
| Edwards, DG; Kirkman, DL; Martens, CR | 1 |
| Atzler, D; Baum, C; Blankenberg, S; Böger, RH; Gori, T; Johannsen, SS; Lackner, KJ; Münzel, T; Ojeda, FM; Schnabel, RB; Schwedhelm, E; Sinning, CR; Wild, PS; Zeller, T | 1 |
| Banderali, G; Cefalo, G; Giovannini, M; Lassandro, C; Moretti, F; Radaelli, G; Salvatici, E; Verduci, E | 1 |
| Aly, H; El Melegy, S; El Shikh, T; El-Batch, M; Rowisha, M | 1 |
| Ajtay, Z; Cziráki, A; Kiss, I; Kustán, P; Lenkey, Z; Németh, Á; Németh, B; Sulyok, E | 1 |
| Antonelli-Incalzi, R; Battistoni, F; Chiurco, D; Costanzo, L; Pedone, C; Santangelo, S | 1 |
| Afsar, B; Covic, A; Eyileten, T; Gezer, M; Johnson, RJ; Kanbay, M; Karaman, M; Oguz, Y; Ortiz, A; Saglam, M; Siriopol, D; Unal, HU; Verim, S; Vural, A; Yilmaz, MI | 1 |
| Chrysis, D; Efthymiadou, A; Kritikou, D; Mermigka, A; Spiliotis, BE | 1 |
| Guo, BC; Hsu, CP; Lee, TS; Lin, SJ; Lu, TM; Shyue, SK; Zhao, JF | 1 |
| Hussain, SS; Mukherjee, D; Tyroch, AH | 1 |
| André, E; Benamouzig, R; Bunouf, P; Deveaux, A; Fouillet, H; Hermier, D; Huneau, JF; Lantoine-Adam, F; Mariotti, F; Mathé, V; Petzke, KJ | 1 |
| André, E; Benamouzig, R; Bunouf, P; Deveaux, A; Fouillet, H; Hermier, D; Huneau, JF; Lantoine-Adam, F; Mariotti, F; Mathé, V; Pham, I; Sadi, S; West, SG | 1 |
| Chybicka, A; Doroszko, A; Jakubowski, M; Mazur, G; Niedzielska, E; Porwolik, J; Szahidewicz-Krupska, E; Szuba, A; Turek-Jakubowska, A | 1 |
| Boaz, M; Ganz, T; Gilad, S; Limor, R; Stern, N; Wainstein, J | 1 |
| Chen, XL; Gao, XR; Lao, MC; Liu, LJ; Lu, GH; Luo, CF; Zhai, YS | 1 |
| Dagnelie, PC; Henry, RM; Koster, A; Kroon, AA; Schalkwijk, CG; Schaper, N; Scheijen, J; Schram, MT; Sep, SJ; Smit, AJ; Stehouwer, CD; van der Kallen, CJ; van Eupen, MG; van Sloten, TT | 1 |
| Bode-Böger, SM; Bornstein, SR; Brilloff, S; Brocker, C; Burdin, DV; Demyanov, AV; Gonzalez, F; Jarzebska, N; Kolobov, AA; Maas, R; Martens-Lobenhoffer, J; Mieth, M; Rodionov, RN; Samusik, N; Soshnev, AA; Weiss, N | 1 |
| Barrett, ML; Brooks, JR; Cantilena, L; Chung, M; Costello, RB; Deuster, P; Dwyer, J; Giancaspro, GI; Gorecki, DK; Hardy, ML; Jones, D; Jordan, SA; Low Dog, T; Marles, RJ; Maughan, RJ; Oketch-Rabah, H; Osterberg, RE; Rodda, BE; Sarma, ND; Valerio, LG; Wolfe, RR; Zuniga, JM | 1 |
| Lieb, W; Maas, R; Schlesinger, S; Sonntag, SR | 1 |
| Peng, C; Wong, CC | 1 |
| Banerjee, T; Coresh, J; Hai, X; Hostetter, TH; Hwang, S; Melamed, ML; Meyer, TW; Powe, NR; Shafi, T | 1 |
| Cseprekál, O; Egresits, J; Farkas, K; Godina, G; Járai, Z; Kielstein, J; Kiss, I; Kümpers, P; Lukasz, A; Marton, A; Nemcsik, J; Németh, ZK; Sallai, L; Tabák, Á; Tislér, A | 1 |
| Abe, Y; Arai, Y; Hirata, T; Ohkuma, K; Takayama, M; Takebayashi, T | 1 |
| Gongora, E; Nair, N | 1 |
| Chen, C; Hei, Z; Li, X; Liu, J; Ruan, Y; Ye, Y; Zhou, S; Zhu, Q | 1 |
| Abdel Hamid, SG; El-Mesallamy, HO; Gad, MZ | 1 |
| Alfthan, G; Hutri-Kähönen, N; Jula, A; Juonala, M; Kähönen, M; Laaksonen, R; Lehtimäki, T; Päivä, H; Raitakari, OT; Viikari, J | 1 |
| Zsuga, J | 1 |
| Aletta, JM; Hu, JC | 1 |
| Alchanatis, M; Dimitriadis, K; Kallikazaros, I; Manolis, A; Stefanadis, C; Thomopoulos, C; Tousoulis, D; Tsiachris, D; Tsioufis, C | 1 |
| Formiguera, X; Galán, A; Rey-Joly, C | 1 |
| Aso, Y | 1 |
| Kaida, Y; Matsumoto, Y; Okuda, S; Ueda, S; Yamagishi, S | 1 |
| Avci, E; Bilgi, C; Cakir, E; Coskun, S; Kurt, Y; Ozgur Akgul, E | 1 |
| Krzyzanowska, K; Mittermayer, F; Wolzt, M | 1 |
| Getino, MA; Jarque, A; Lozano, L; Mora-Fernández, C; Navarro, JF; Sánchez, R | 1 |
| Agustí, AG; Alonso, A; Ayllón, O; Barceló, A; de la Peña, M; González, C; Pérez, G; Piérola, J; Vega-Agapito, MV | 1 |
| Yilmaz, MB; Yontar, OC | 1 |
| Krzyzanowska, K; Mittermayer, F; Schernthaner, G; Wolzt, M | 2 |
| Aller, R; Conde, R; de Luis, DA; Gonzalez-Sagrado, M; Izaola, O | 1 |
| Bode-Böger, SM; Ertl, T; Lakatos, O; Martens-Lobenhoffer, J; Sulyok, E; Vida, G | 1 |
| El-Mesallamy, HO; Gad, MZ; Sanad, EF | 1 |
| Bai, Y; Chen, J; Hui, R; Sun, K; Sun, L; Yang, T | 1 |
| Geesey, ME; King, DE; Mainous, AG | 1 |
| Celik, T; Iyisoy, A; Jata, B; Yuksel, C | 1 |
| Egger, G; Holt, DW; Kiechl, S; Lee, T; Mayr, M; Santer, P; Thompson, G; Tsimikas, S; Willeit, J; Xu, Q | 1 |
| Mallamaci, F; Zoccali, C | 1 |
| Gnyp, W; Grela, W; Koszowski, B; Sobczak, A; Szołtysek-Bołdys, I; Zielińska-Danch, W | 1 |
| Benjamin, EJ; Benndorf, RA; Böger, RH; Maas, R; Schulze, F; Schwedhelm, E; Sullivan, LM; Vasan, RS; Wang, TJ; Xanthakis, V | 1 |
| Mangoni, AA; Wadham, C | 1 |
| Bianchi, M; De Gennaro Colonna, V; Ferrario, P; Morelli, F; Pascale, V; Pascale, W; Tomasoni, L; Turiel, M | 1 |
| Ayer, JG; Celermajer, DS; Harmer, JA; Marks, GB; Nakhla, S; Ng, MK; Raitakari, OT; Xuan, W | 1 |
| Bush, RL; Christou, D; McNeal, CJ; Santiago, J; Shepherd, LG; Wilson, DP; Wu, GY | 1 |
| Benndorf, RA; Böger, RH; Maas, R; Riederer, U; Schulze, F; Schwedhelm, E; Sullivan, LM; Vasan, RS; Xanthakis, V | 1 |
| Brennan, DM; Cho, L; Hazen, SL; Tang, WH; Wang, Z | 1 |
| Alfieri, O; Bosi, E; Castiglioni, A; Catapano, AL; Formica, F; La Canna, G; Lucotti, P; Monti, L; Pala, MG; Paolini, G; Piatti, P; Rossodivita, A; Setola, E | 1 |
| Böger, RH; Maas, R; Schulze, F; Schwedhelm, E | 2 |
| Fuchs, D; Kurz, K; Sarcletti, M; Teerlink, T; Weiss, G; Zangerle, R | 2 |
| Chirkov, YY; Horowitz, JD; McNeil, JJ; Ngo, DT; Nightingale, AK; Sverdlov, AL; Willoughby, SR | 1 |
| Creager, MA | 1 |
| Cardounel, AJ; Karuppiah, K; Pope, AJ | 1 |
| Luo, Z; Palm, F; Teerlink, T; Wilcox, CS | 1 |
| Mangoni, AA | 1 |
| Kocaman, SA | 1 |
| Hermsdorff, HH; Martínez, JA; Puchau, B; Zulet, MA | 1 |
| Abedini, S; Fellstrøm, B; Holdaas, H; Holme, I; Jardine, A; März, W; Meinitzer, A; Weihrauch, G | 1 |
| Böger, RH | 11 |
| Fair, JM; Fortmann, SP; Go, AS; Hlatky, MA; Iribarren, C; Sydow, K; Tsao, PS; Varady, A | 1 |
| Blackwell, S | 1 |
| Sledzinski, M; Sledzinski, T; Smolenski, RT; Swierczynski, J | 1 |
| Bettari, L; Bugatti, S; Dei Cas, A; Dei Cas, L; Kamp, O; Metra, M; Petrini, N | 1 |
| Ai, M; Ausman, LM; Freed, A; Harding, SV; Jones, PJ; Kuvin, JT; Lichtenstein, AH; Matthan, NR; Otokozawa, S; Rideout, TC; Schaefer, EJ; Vega-López, S | 1 |
| Fahs, CA; Heffernan, KS; Patvardhan, EA; Ranadive, SM | 1 |
| Bode-Böger, SM; David, S; Fliser, D; Haller, H; Kielstein, JT; Kliem, V; Kümpers, P; Lukasz, A; Martens-Lobenhoffer, J | 1 |
| Förstermann, U | 1 |
| Soda, K | 1 |
| Arend, M; Atzler, D; Böger, RH; Cardounel, AJ; Cordasic, N; Heusinger-Ribeiro, J; Hilgers, KF; Jacobi, J; Maas, R; Pope, AJ; Schwedhelm, E; Strobel, J | 1 |
| Evans, A; Gey, KF; Gilchrist, SE; McKinley, MC; O'Doherty, MG; Skidmore, PM; Woodside, JV; Yarnell, JW; Young, IS | 1 |
| Dohi, Y; Ito, A; Itoh, T; Kajikuri, J; Koyama, K; Kumagai, H; Nakamura, H; Nishio, T; Ohte, N; Sano, A; Yamamoto, J | 1 |
| Aguila, MB; Brunini, TC; Catta-Preta, M; Mandarim-de-Lacerda, CA; Martins, MA; Mendes-Ribeiro, AC | 1 |
| Ayhan, SS; Bacaksiz, A; Kayrak, M; Taner, A; Ulgen, MS; Unlü, A; Vatankulu, MA; Yazici, M | 1 |
| Azqueta, M; Cases, A; Coll, E; Collado, S; Cruzado, JM; de la Torre, B; Deulofeu, R; Guerrero, L; Nicolau, C; Pons, M; Vera, M | 1 |
| Artusi, C; Boffa, GM; Ivanova, M; Plebani, M; Zaninotto, M | 1 |
| Aguirre, M; Aldámiz-Echevarría, L; Andrade, F; Ariceta, G; Azcona, I; Lage, S; Prado, C; Prieto, JA; Rodríguez-Soriano, J; Sanjurjo, P | 1 |
| Berta, A; Biri, B; Bodnár, N; Gesztelyi, R; Kéki, S; Kemény-Beke, Á; Kerekes, G; Szántó, S; Szekanecz, Z; Szodoray, P; Zsuga, J; Zsuga, M | 1 |
| Aleksandrowicz-Wrona, E; Lichodziejewska-Niemierko, M; Małgorzewicz, S; Rutkowski, B; Świetlik, D; Łysiak-Szydłowska, W | 1 |
| Alfthan, G; Hutri-Kähönen, N; Juonala, M; Kähönen, M; Laaksonen, R; Laitinen, T; Lehtimäki, T; Päivä, H; Raitakari, OT; Taittonen, L; Viikari, J | 1 |
| Connelly, JM; Grinspoon, SK; Hemphill, LC; Makimura, H; Stanley, TL; Sun, N | 1 |
| Engin-Üstün, Y; Kafkasli, A; Kali, Z; Karabulut, AB; Meydanli, M; Turan, F; Türkçüoğlu, I | 1 |
| Bautista-Ortega, J; Ruiz-Feria, CA | 1 |
| Bruno, RM; Gori, T; Münzel, T; Taddei, S | 1 |
| Ayhan, S; Demir, K; Erdem, S; Karabag, T; Kaya, A; Kaya, C; Koc, F; Tokac, M; Unlu, A; Vatankulu, MA | 1 |
| Boehm, BO; Drechsler, C; Kielstein, JT; März, W; Meinitzer, A; Pilz, S; Ritz, E; Winkelmann, BR | 1 |
| Assumpção, CR; Brunini, TM; Godoy-Matos, AF; Mann, GE; Mendes-Ribeiro, AC; Pereira, NR; Siqueira, MA | 1 |
| Aydin, M; Batioglu, S; Erdogan, G; Kilic, S; Yilmaz, N; Zulfikaroglu, E | 1 |
| Kanazawa, I; Nabika, T; Notsu, Y; Sugimoto, T; Yamaguchi, T; Yano, S | 1 |
| Atzler, D; Benndorf, RA; Böger, RH; Darius, H; Diehm, C; Endres, HG; Lüneburg, N; Maas, R; Schwedhelm, E; Thiem, U; von Stritzky, B | 1 |
| Ahmetaj, B; Arrigoni, F; Leiper, J | 1 |
| Dalton, RN; Dunger, DB; Marcovecchio, ML; Turner, C; Widmer, B | 1 |
| Chung, MY; Hsu, CP; Lin, MW; Lin, SJ; Lu, TM | 2 |
| Jin, LJ; Li, X; Tse, HF | 1 |
| Jackson, G; Wierzbicki, AS | 1 |
| Aggelis, A; Alexopoulos, N; Ioakeimidis, N; Rokkas, K; Samentzas, A; Stefanadis, C; Terentes-Printzios, D; Vlachopoulos, C | 1 |
| Huang, LT; Tain, YL | 1 |
| Gu, LQ; Li, FY; Liu, JM; Liu, Y; Ning, G; Zhang, MJ; Zhao, L; Zhao, YJ; Zhu, W | 1 |
| Drexel, V; Emslander, I; Halle, M; Hanssen, H; Hertel, G; Kotliar, KE; Lorang, D; Nickel, T; Pressler, A; Schmidt-Trucksäss, A; Schuster, T; Sisic, Z; Weis, M | 1 |
| Aasarød, K; Åsberg, A; Bigonah, A; Hatlen, G; Hov, GG; Sagen, E | 1 |
| Beckmann, B; Chobanyan-Jürgens, K; Das, AM; Illsinger, S; Kanzelmeyer, N; Lücke, T; Tsikas, D; Vaske, B | 1 |
| Atzler, D; Bache, RJ; Böger, RH; Chen, Y; Fassett, J; Guo, H; Hu, X; Lu, Z; Schwedhelm, E; Xu, X; Zhang, P | 1 |
| Cameron, JD; Moran, LJ; Strauss, BJ; Teede, HJ | 1 |
| Boehm, BO; Grammer, TB; März, W; Meinitzer, A; Pilz, S; Sourij, H; Winkelmann, BR | 1 |
| Boger, R; Maas, R; Malatino, L; Mallamaci, F; Mattace Raso, F; Rapisarda, F; Seck, MS; Sijbrands, E; Tripepi, G; Witteman, J; Zoccali, C | 1 |
| Bluck, LJ; Feelisch, M; Siervo, M; Stephan, BC | 1 |
| Cooke, JP; Ghebremariam, YT | 1 |
| Bogner, M; Elmadfa, I; Fabian, E | 1 |
| Agusti, AG; Alonso, A; Ayllón, O; Barbè, F; Barceló, A; de la Peña, M; Esquinas, C; Piérola, J; Sanchez-de la Torre, M | 1 |
| Förstermann, U; Sessa, WC | 1 |
| Oikonomou, E; Papageorgiou, N; Papavassiliou, AG; Siasos, G; Stefanadis, C; Stougianos, P; Tousoulis, D | 1 |
| Bicchieri, L; Di Gennaro, C; Manfredi, G; Montanari, A; Palombi, F; Pellegrino, A; Pinelli, S; Saccani-Jotti, G; Sansoni, P; Venturi, N | 1 |
| Atzler, D; Baldus, S; Blankenberg, S; Böger, RH; D'Alecy, LG; Ehmke, H; Gadegbeku, CA; Hellwinkel, O; Kielstein, JT; Klinke, A; Kubala, L; Lau, D; Lund, N; Maas, R; Meinertz, T; Pekarova, M; Schmidt-Haupt, R; Schwedhelm, E; Slocum, JL; Sydow, K; Tsikas, D; von Leitner, EC; Willems, S | 1 |
| Cotti, E; Deidda, M; Dessì, C; Flore, G; Longu, G; Madeddu, C; Mercuro, G; Piras, A; Zedda, A | 1 |
| Anderssohn, M; Böger, RH; Fourie, CM; Glyn, MC; Huisman, HW; Lüneburg, N; Malan, L; Malan, NT; Mels, CM; Schutte, AE; Schutte, R; Smith, W; Van Rooyen, JM | 1 |
| Bonnefont-Rousselot, D; Borderie, D; Frombaum, M; Le Clanche, S | 1 |
| Fukasawa, H; Furuya, R; Hishida, A; Isobe, S; Kinoshita, N; Kumagai, H; Miyata, T | 1 |
| Inaba, M; Koyama, H; Nishizawa, Y | 1 |
| Wilcox, CS | 1 |
| Chen, J; Chen, R; Goligorsky, MS; Lu, CY; Moskowitz-Kassai, E; Sanduski, K; Špes, A; Turk, B; Xavier, S | 1 |
| Bodamer, OA; Huemer, M; Mayr, D; Möslinger, D; Mühl, A; Schmid, I; Simma, B; Ulmer, H | 1 |
| Linz, TH; Lunte, SM; Snyder, CM | 1 |
| Fijorek, K; Goralczyk, T; Tisonczyk, J; Undas, A | 1 |
| Brunini, TM; de Souza, PF; Ferraz, MR; Mendes-Ribeiro, AC; Moss, MB; Oliveira, MB; Pinto, VL; Siqueira, MA | 1 |
| Alsagaff, MY; Aminuddin, M; Thaha, M; Tomino, Y; Yogiantoro, M; Yogiarto, RM | 1 |
| Caplin, B; Leiper, J | 1 |
| Kimura, K | 1 |
| Alizadeh, M; Daneghian, S; Estakhri, R; Gargari, BP; Ghaffari, A; Ostadrahimi, A; Safaeiyan, A | 1 |
| Catanzaro, R; Jain, S; Kumari, A; Lorenzetti, A; Marotta, F; Polimeni, A; Soresi, V; Yadav, H | 1 |
| Brinkworth, GD; Buckley, JD; Clifton, PM; Noakes, M; Norman, RJ; Thomson, RL | 1 |
| Derbent, A; Gumus, II; Karakurt, F; Kargili, A; Kasapoglu, B; Kaygusuz, I; Uysal, S | 1 |
| Wierzbicki, AS | 1 |
| Auge, D; Endress, B; Fromm, MF; König, J; Maas, R; Mieth, M; Strobel, J | 1 |
| Balwierz, W; Ćwiklińska, M; Grodzicki, TK; Gryglewska, B; Kwater, A; Strach, M; Sulicka, J; Surdacki, A | 1 |
| Katsanos, CS; Mandarino, LJ; Meyer, C; Puga, GM | 1 |
| Clifton, PM; Moran, LJ; Noakes, M; Norman, RJ; Wittert, GA | 1 |
| Aussel, C; Bahri, S; Chaumeil, JC; Crenn, P; Curis, E; Cynober, L; Moinard, C; Sfar, S; Zerrouk, N | 1 |
| Brunini, TM; Cheniaux, E; de Bem, GF; Ferraz, MR; Fontoura, PC; Matsuura, C; Mendes-Ribeiro, AC; Pinto, VL; Resende, Ade C | 1 |
| Chen, XM; Hu, CP; Jiang, JL; Li, YJ | 1 |
| Ahmed, IK; Ali, SR; Elmageed, AM; Saleh, BI | 1 |
| Aldámiz-Echevarría, L; Andrade, F | 1 |
| Angelidi, A; Dimitriadis, G; Foussas, S; Gritzapis, A; Matsagos, S; Melidonis, A; Panoutsopoulos, GI; Protopsaltis, I; Raptis, S; Sergentanis, TΝ; Tzirogiannis, K | 1 |
| Hoang, HH; Meininger, CJ; Padgham, SV | 1 |
| Aydin, Z; Gurdal, A; Gursu, M; Karadag, S; Kazancioglu, R; Koldas, M; Kumbasar, B; Ozturk, S; Uzun, S; Yegen, M | 1 |
| Dimitroulas, T; Kitas, GD; Sandoo, A | 1 |
| Gao, Y; Vanhoutte, PM | 1 |
| Attia, JR; Carru, C; Mangoni, AA; McEvoy, M; Zinellu, A | 1 |
| Fujiwara, N; Nakamura, M; Okumura, K; Osanai, T; Osawa, H; Saitoh, M; Sasaki, S; Tomita, H; Yamabe, H | 1 |
| Zoccali, C | 3 |
| Hansson, L; Hedner, T; Himmelmann, A | 1 |
| Chan, JC; Chan, NN | 1 |
| Appleton, J | 1 |
| Antoniades, C; Goumas, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
| Busch, M; Franke, C; Franke, S; Müller, A; Niwa, T; Stein, G; Wendt, T | 1 |
| de Jong, S; Neele, SJ; Netelenbos, JC; Stehouwer, CD; Teerlink, T | 1 |
| Bode-Böger, SM; Fliser, D; Haller, H; Kielstein, JT | 1 |
| Anderstam, B; Bárány, P; Fehrman-Ekholm, I; Heimbürger, O; Lindholm, B; Pecoits-Filho, R; Qureshi, AR; Rodríguez Ayala, E; Stenvinkel, P; Suliman, ME | 1 |
| Bonfigli, AR; Coppa, G; Gambini, A; Marra, M; Testa, I; Testa, R | 1 |
| Braun, A; Busch, M; Fleck, C; Franke, S; Müller, A; Müller, UA; Schiel, R; Stein, G | 1 |
| Kenemans, P; Post, MS; Stehouwer, CD; Teerlink, T; van der Mooren, MJ; Verhoeven, MO | 1 |
| Magota, K; Murakami, S; Nakamura, M; Okumura, K; Osanai, T; Osawa, H; Saitoh, M; Sasaki, S; Tomita, H; Yamabe, H | 1 |
| Böger, RH; Cooke, JP; Vallance, P | 1 |
| Böger, RH; Zoccali, C | 1 |
| Münzel, T; Sydow, K | 1 |
| Cooke, JP | 4 |
| Dayal, S; Lentz, SR; Rodionov, RN | 1 |
| Mallamaci, F; Tripepi, G; Zoccali, C | 1 |
| Cooke, JP; Gao, SZ; Kledal, TN; Lin, KY; Mocarski, ES; Panchal, SN; Valantine, HA; Weis, M | 1 |
| Hovind, P; Parving, HH; Stehouwer, CD; Tarnow, L; Teerlink, T | 1 |
| Leiper, J; Vallance, P | 1 |
| Llorens, S; Nava, E | 1 |
| Boak, L; Chin-Dusting, JP | 1 |
| Alfarano, C; Banchelli, G; Cecchi, E; Cerbai, E; Cioni, L; Lodovici, M; Mugelli, A; Pirisino, R; Raimondi, L; Sartiani, L; Visioli, F | 1 |
| Laaksonen, R; Valkonen, VP | 1 |
| Creager, MA; Gornik, HL | 1 |
| Ahrén, B; Björk, J; Cavallin-Ståhl, E; Erfurth, EM; Garwicz, S; Link, K; Moëll, C; Thilén, U | 1 |
| Yoshizumi, M | 1 |
| Bode-Böger, SM; Böger, RH; Fliser, D; Frölich, JC; Haller, H; Kielstein, JT; Lonnemann, G; Martens-Lobenhoffer, J | 1 |
| Elliott, WG; Gurbuz, AT; Zia, AA | 1 |
| Kumar, J; Shah, SV | 1 |
| Everett, CJ; Mainous, AG; Wells, BJ | 1 |
| Aso, Y; Okumura, K; Yoshida, N | 1 |
| Böger, RH; Ron, ES | 1 |
| Brodsky, SV; Chen, J; Goligorsky, MS; Li, H; O'Riordan, E; Smirnova, I | 1 |
| Cutrupi, S; Malatino, LS; Mallamaci, F; Tripepi, G; Zoccali, C | 1 |
| Csernus, K; Czakó, M; Erhardt, E; Kosztolányi, G; Molnár, D | 1 |
| Markov, KhM | 2 |
| Jackson, G; Lambert-Hammill, M; Lumb, PJ; Lyttle, K; Solomon, H; Wierzbicki, AS | 1 |
| Enia, G; Mallamaci, F; Panuccio, V; Tripepi, G; Zoccali, C | 1 |
| Akgul, EO; Beyhan, Z; Bilgi, C; Cakir, E; Erbil, MK; Erturk, K; Ozcan, O; Yaman, H | 1 |
| Bickel, C; Blankenberg, S; Cambien, F; Espinola-Klein, C; Jachmann, N; Lackner, KJ; Lubos, E; Münzel, T; Peetz, D; Post, F; Rupprecht, HJ; Schnabel, R; Tiret, L | 1 |
| Bultink, IE; Dijkmans, BA; Heijst, JA; Teerlink, T; Voskuyl, AE | 1 |
| Kielstein, JT; Zoccali, C | 2 |
| Boeger, R; Fatuzzo, P; Maas, R; Malatino, L; Mallamaci, F; Spoto, B; Testa, A; Tripepi, G; Zoccali, C | 1 |
| Böger, RH; Freese, R; Maas, R; Schulze, F; Schwedhelm, E; Silberhorn, E | 1 |
| Anthony, S; Hubank, M; Leiper, JM; Smith, CL; Vallance, P | 1 |
| Teerlink, T | 1 |
| Bauersachs, J; Thum, T | 1 |
| Acikel, C; Aydin, A; Caglar, K; Cakir, E; Erbil, K; Eyileten, T; Genctoy, G; Ozcan, O; Ozgurtas, T; Saglam, M; Sonmez, A; Tasar, M; Vural, A; Yilmaz, MI; Zoccali, C | 1 |
| Pogacnik, T; Pretnar-Oblak, J; Sabovic, M; Zaletel, M; Zvan, B | 1 |
| Higgs, EA; Moncada, S | 1 |
| Leiper, JM | 1 |
| Grdić, M; Huber, K; Maurer, G; Niessner, A; Penka, M; Richter, B; Simeon-Rudolf, V; Steiner, S; Strasser, B; Wojta, J; Ziegler, S; Zorn, G | 1 |
| Roth, E; Wessner, B | 1 |
| Francesconi, M; Krzyzanowska, K; Mittermayer, F; Pleiner, J; Wiesinger, GF; Wolzt, M | 1 |
| Dayal, S; Lentz, SR | 1 |
| Cooke, JP; Mondon, CE; Sydow, K | 1 |
| Laaksonen, R; Tuomainen, TP; Valkonen, VP | 1 |
| Maas, R | 1 |
| Morris, SM | 1 |
| Matthai, WH | 1 |
| Cambou, JP; Cottin, Y; Danchin, N; Empana, JP; Ferrières, J; Jouven, X; Paillard, F; Thomas, D; Valensi, P; Zeller, M | 1 |
| Colao, A; Di Somma, C; Lombardi, G; Pivonello, R; Rota, F; Savastano, S; Spiezia, S | 1 |
| Czekalski, S; Oko, A; Pawlaczyk, K | 1 |
| Brouwer, CB; Rauwerda, JA; Smulders, YM; Spoelstra-de Man, AM; Stehouwer, CD; Teerlink, T | 1 |
| Bellien, J; Joannides, R; Thuillez, C | 1 |
| Cibulka, R; Racek, J; Rajdl, D; Siroká, R | 1 |
| Branca, F; Bugel, S; Dahlman-Wright, K; Dierkes, J; Ferrari, M; Hall, WL; Hallund, J; Huebner, U; Koebnick, C; Nilsson, M; Reimann, M; Vafeiadou, K; Williams, CM | 1 |
| Bode-Boeger, SM; Cooke, JP; Fliser, D; Kielstein, JT; Salpeter, SR | 1 |
| Goss, M; Kopieczna-Grzebieniak, E | 1 |
| Das, P; Hamdalla, H; Jozic, J; Moliterno, DJ; Mukherjee, D; Steinhubl, SR; Ziada, K | 1 |
| Nijveldt, RJ; Prins, HA; Richir, MC; Siroen, MP; Teerlink, T; van Leeuwen, PA | 1 |
| Barth, SW; Bub, A; Hahn, A; Hülsmann, O; Kressel, G; Kühn-Velten, WN; Lichtinghagen, R; Schmitt, B; Stichtenoth, DO; Ströhle, A; Wolters, M | 1 |
| Carmichael, JD; Danoff, A; Ferris, S; Kleinberg, DL; Lesser, ML; Livote, E; Milani, D; Reitz, RE; Roubenoff, R | 1 |
| Hirata, Y | 1 |
| Amighi, J; Exner, M; Krzyzanowska, K; Minar, E; Mittermayer, F; Mlekusch, W; Müller, M; Sabeti, S; Schillinger, M; Wolzt, M | 1 |
| Baylis, C | 1 |
| Balestrieri, ML; Ignarro, LJ; Napoli, C | 1 |
| Hishida, A; Ikegaya, N; Kato, A; Kumagai, H; Maruyama, Y; Sakurai, M; Takita, T; Uno, S | 1 |
| Barnard, K | 1 |
| Giles, TD | 1 |
| Boehm, BO; Halwachs-Baumann, G; März, W; Meinitzer, A; Seelhorst, U; Wellnitz, B; Winkelmann, BR | 1 |
| Cooke, JP; Kielstein, JT | 1 |
| Podgórski, M; Szuba, A | 1 |
| Ardigo, D; Franzini, L; Pachinger, O; Piatti, PM; Reaven, GM; Stüehlinger, M; Valtueña, S; Zavaroni, I | 1 |
| Brunini, TM; Lugon, JR; Mendes-Ribeiro, AC; Moss, MB; Santos, SF; Siqueira, MA | 1 |
| Fliser, D; Kielstein, JT | 1 |
| Böger, RH; Dentz, L; Haddad, M; Hiltmeyer, N; Klöss, T; Kuss, O; Maas, R; Schwedhelm, E; Standl, T; Thoms, W | 1 |
| Smith, CL | 1 |
| Fukami, K; Matsumoto, Y; Okuda, S; Ueda, S; Yamagishi, SI | 1 |
| Lipman, ML; Mann, JF; Schiffrin, EL | 1 |
| Durante, W; Johnson, FK; Johnson, RA | 1 |
| Alfthan, G; Juonala, M; Kähönen, M; Laitinen, T; Marniemi, J; Raitakari, OT; Taittonen, L; Viikari, JS | 1 |
| Busch, M; Franke, S; Stein, G; Wolf, G | 1 |
| Bekpinar, S; Can, A; Cetinalp-Demircan, P; Orhan, Y; Unlucerci, Y | 1 |
| Blankenberg, S; Schnabel, R | 1 |
| Chin-Dusting, JP; Kaye, DM; Willems, L | 1 |
| Firat, H; Ozkan, Y; Simşek, B; Torun, M; Yardim-Akaydin, S | 1 |
| Baysal, E; Maden, O; Ozeke, O; Sasmaz, A; Selcuk, H; Selcuk, MT; Temizhan, A; Ulupinar, H | 1 |
| Luo, Z; Onozato, ML; Palm, F; Wilcox, CS | 1 |
| Buring, JE; Cheng, S; Erlich, HA; Lindpaintner, K; Ridker, PM; Rifai, N; Zee, RY | 1 |
| Bai, Y; Hui, R | 1 |
| Kaida, Y; Okuda, S; Ueda, S; Yamagishi, S | 1 |
| Arning, E; Bottiglieri, T; Cooke, JP; Dayoub, H; Faraci, FM; Lentz, SR; Lynch, C; Rodionov, RN | 1 |
| Fici, F; Hekim, N; Oğuz, A; Uzunlulu, M; Yalçin, Y; Yorulmaz, E | 1 |
| Andreotti, F; Coluzzi, G; Marzo, F; Santucci, E | 1 |
| Jorsal, A; Lajer, M; Parving, HH; Rossing, P; Tarnow, L; Teerlink, T | 1 |
| Axelsson, J; Carrero, JJ; Heimbürger, O; Lindholm, B; Massy, Z; Stenvinkel, P | 1 |
| Fauler, G; Grandits, N; Gruber, HJ; Mangge, H; Mayer, C; Wilders-Truschnig, M | 1 |
| Boeger, RH; Deussen, A; Henle, T; Pexa, A; Schwedhelm, E | 1 |
| Aguirre, M; Aldámiz-Echevarría, L; Andrade, F; Ariceta, G; Elorz, J; Martin, S; Prieto, JA; Rodríguez-Soriano, J; Sanjurjo, P | 1 |
| Hemphill, L; Miller, KK; Utz, AL; Yamamoto, A | 1 |
| Brunini, TM; Ferraz, MR; Mendes-Ribeiro, AC; Okinga, A; Pinto, VL | 1 |
| Lentz, SR; Rodionov, RN | 1 |
| Fujita, T; Kumon, K; Naito, Y; Nakajima, N; Tanaka, K | 1 |
| Nowicki, M; Ritz, E; Vallance, P | 1 |
| de Berrazueta, JR | 1 |
| Thiemermann, C | 1 |
| Haefeli, WE; Lüscher, TF | 1 |
| Dioh, A; Hennen, G | 1 |
| Fahey, TJ; Fantini, GA; Shires, GT; Yoshioka, T | 1 |
| Connell, JM; Elliott, HL; Petrie, JR; Ueda, S; Webb, DJ | 1 |
| Drexler, H; Heitzer, T; Just, H; Kurz, S; Luoma, J; Münzel, T; Olschewski, M; Ylä-Herttuala, S | 1 |
| Ritz, E | 1 |
| Ruetten, H; Thiemermann, C; Vane, JR; Wu, CC | 1 |
| Bhagat, K; Vallance, P | 1 |
| Cosentino, F; Lüscher, TF | 1 |
| Blanché, H; Dussoix, P; Froguel, P; Garin, MC; James, RW; Passa, P; Ruiz, J | 1 |
| Borghetti, A; Garini, G; Savazzi, G | 1 |
| Cooke, JP; Dzau, VJ | 1 |
| Yamada, Y; Yokota, M | 1 |
| Marín, J; Rodríguez-Martínez, MA | 1 |
| Cooke, JP; Maxwell, AJ | 1 |
| Kario, K; Koide, M; Matsuo, T | 1 |
| Cockcroft, JR; Wilkinson, IB | 1 |
| de Lorgeril, M | 1 |
| Quyyumi, AA | 1 |
| Fisman, EZ; Motro, M; Tenenbaum, A | 1 |
| Banga, JD; de Groot, PG; Grobbee, DE; Roest, M; Sixma, JJ; Tempelman, MJ; van der Schouw, YT | 1 |
| De Lucia, D; De Rosa, N; Farzati, B; Giugliano, D; Ingrosso, D; Marfella, R; Nappo, F; Perna, AF | 1 |
| Korpela, R; Nittynen, L; Nurminen, ML; Vapaatalo, H | 1 |
| Herbaczyńska-Cedro, K | 1 |
| Kendler, BS | 1 |
| Aubó, C; Elosua, R; Marrugat, J; Sala, J; Sentí, M; Tomás, M | 1 |
| Beyer, J; Daniel, WG; Garlichs, CD; Mügge, A; Plötze, K; Schellong, S; Schmeisser, A; Zhang, H | 1 |
| Liesivuori, J; Pennanen, S; Penttinen, J | 1 |
| Meininger, CJ; Wu, G | 1 |
| Bode-Böger, SM; Böger, RH | 2 |
| Goumas, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
| Chan, N; Vallance, P | 1 |
| Oike, M | 1 |
| Brown, AA; Hu, FB | 1 |
| Gruenwald, I; Vardi, Y | 1 |
| Tiefenbacher, CP | 1 |
| Baldwin, SN; Balwin, SN; Cheng, JW | 1 |
| Bauer, JA; Mihm, MJ; Wattanapitayakul, SK; Young, AP | 1 |
| Lupattelli, G; Mannarino, E; Marchesi, S; Roscini, AR; Siepi, D; Sinzinger, H; Vaudo, G | 1 |
| Bautista, L; Casas, JP; López-Jaramillo, P; Morillo, CA; Serrano, NC | 1 |
| Bruinsma, KA; Maxwell, AJ | 1 |
| Du, J; Li, J; Tang, C; Yao, X; Zhang, B; Zhang, Y | 1 |
| Albala, C; Carrasco, E; Martínez, JA; Montalvo, D; Pérez-Bravo, F; Santos, JL | 1 |
| Abbasi, F; Chu, JW; Cooke, JP; Lamendola, C; McLaughlin, TL; Reaven, GM; Stühlinger, MC; Tsao, PS | 1 |
| Nash, DT | 1 |
| Asherova, L; Chagan, L; Cheng, JW; Ioselovich, A | 1 |
| Abe, K; Kumagai, N; Mouri, T; Seki, T; Yoshinaga, K | 1 |
| Seiter, K | 1 |
185 review(s) available for arginine and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of L-Citrulline Supplementation and Aerobic Training on Vascular Function in Individuals with Obesity across the Lifespan.
Topics: Adolescent; Adult; Aged; Arginine; Atherosclerosis; Blood Pressure; Cardiometabolic Risk Factors; Cardiovascular Diseases; Child; Citrulline; Dietary Supplements; Endothelium, Vascular; Exercise; Female; Humans; Hypertension; Longevity; Male; Metabolic Diseases; Middle Aged; Nitric Oxide; Obesity; Vascular Stiffness; Vasodilation; Young Adult | 2021 |
Clinical and diagnostic relevance of asymmetric and symmetric dimethyl arginine (ADMA/SDMA).
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Humans; Nitric Oxide | 2022 |
Asymmetric dimethylarginine and gestational diabetes mellitus: a systematic review and meta-analysis.
Topics: Arginine; Cardiovascular Diseases; Diabetes, Gestational; Female; Humans; Postpartum Period; Pregnancy | 2023 |
Homoarginine in the cardiovascular system: Pathophysiology and recent developments.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Cardiovascular System; Homoarginine; Humans | 2023 |
A Critical Review on Vasoactive Nutrients for the Management of Endothelial Dysfunction and Arterial Stiffness in Individuals under Cardiovascular Risk.
Topics: Arginine; Cardiovascular Diseases; Citrulline; Endothelium, Vascular; Heart Disease Risk Factors; Humans; Nitric Oxide; Risk Factors; Vascular Stiffness; Vasodilation | 2023 |
Fetoplacental endothelial dysfunction in gestational diabetes mellitus and maternal obesity: A potential threat for programming cardiovascular disease.
Topics: Arginine; Cardiovascular Diseases; Diabetes, Gestational; Female; Humans; Nitric Oxide; Obesity, Maternal; Placenta; Pregnancy | 2023 |
The Second Life of Methylarginines as Cardiovascular Targets.
Topics: Amidohydrolases; Animals; Arginine; Biological Transport; Biomarkers; Cardiovascular Diseases; Cardiovascular System; Disease Susceptibility; Energy Metabolism; Humans; Molecular Targeted Therapy | 2019 |
Protein Arginine Methyltransferases in Cardiovascular and Neuronal Function.
Topics: Animals; Arginine; Cardiovascular Diseases; Cardiovascular System; Humans; Methylation; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases | 2020 |
[Vascular dysfunction in Cardiorenal Syndrome type 4].
Topics: Aorta; Arginine; Autonomic Nervous System Diseases; Bone Diseases, Metabolic; Cardio-Renal Syndrome; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Inflammation; Myocardial Infarction; Oxidative Stress; Phosphorus; Renal Insufficiency, Chronic; Toxins, Biological; Tunica Intima; Uric Acid; Vascular Stiffness; Vasculitis | 2020 |
Intraplatelet L-Arginine-Nitric Oxide Metabolic Pathway: From Discovery to Clinical Implications in Prevention and Treatment of Cardiovascular Disorders.
Topics: Amidohydrolases; Arginine; Blood Platelets; Cardiovascular Diseases; Endothelium, Vascular; Humans; Metabolic Networks and Pathways; Nitric Oxide; Nitric Oxide Synthase; Risk Factors | 2020 |
Non-Histone Arginine Methylation by Protein Arginine Methyltransferases.
Topics: Antineoplastic Agents; Arginine; Cardiovascular Diseases; Enzyme Inhibitors; Epigenesis, Genetic; Histones; Humans; Metabolic Diseases; Methylation; Neoplasms; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; RNA Splicing; Signal Transduction; Transcription Factors | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Asymmetric dimethylarginine level as biomarkers of cardiovascular or all-cause mortality in patients with chronic kidney disease: a meta-analysis.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Cause of Death; Humans; Mortality; Renal Insufficiency, Chronic | 2021 |
Interplay between Oxidative Stress and Nutrient Sensing Signaling in the Developmental Origins of Cardiovascular Disease.
Topics: Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Energy Metabolism; Humans; Nitric Oxide; Nutritional Physiological Phenomena; Oxidative Stress; Reactive Oxygen Species; Signal Transduction | 2017 |
Polycystic ovarian syndrome-associated cardiovascular complications: An overview of the association between the biochemical markers and potential strategies for their prevention and elimination.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Female; Glycation End Products, Advanced; Homocysteine; Humans; Oxidative Stress; Polycystic Ovary Syndrome; Receptor for Advanced Glycation End Products; von Willebrand Factor | 2017 |
AGXT2: An unnegligible aminotransferase in cardiovascular and urinary systems.
Topics: Animals; Arginine; Cardiovascular Diseases; Cardiovascular System; Humans; Kidney Diseases; Transaminases | 2017 |
Nitric oxide bioavailability dysfunction involves in atherosclerosis.
Topics: Animals; Arginine; Atherosclerosis; Biological Availability; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Obesity; Oxidative Stress; Smoking; Vasodilation | 2018 |
Citrulline in health and disease. Review on human studies.
Topics: Anabolic Agents; Animals; Arginine; Athletic Performance; Carbamoyl-Phosphate Synthase I Deficiency Disease; Cardiovascular Diseases; Citrulline; Endothelial Cells; Enterocytes; Female; Humans; Immunity; Male; Ornithine Carbamoyltransferase; Ornithine Carbamoyltransferase Deficiency Disease; Oxidative Stress; Protein Biosynthesis; Urea Cycle Disorders, Inborn | 2018 |
Association of Circulating Levels of ADMA with Carotid Intima-Media Thickness in Patients with CKD: a Systematic Review and Meta-Analysis.
Topics: Arginine; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Humans; Renal Insufficiency, Chronic | 2018 |
HDL in CKD-The Devil Is in the Detail.
Topics: Advanced Oxidation Protein Products; Apolipoprotein A-V; Apolipoprotein L1; Arginine; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Glomerular Filtration Rate; Humans; Lipid Metabolism; MicroRNAs; Renal Insufficiency, Chronic; Serum Amyloid A Protein | 2018 |
Impact of the 719Arg Variant of KIF6 and Major Cardiovascular Events on Patients who Received Statins: A Systematic Review and Meta-Analysis.
Topics: Arginine; Cardiovascular Diseases; Genetic Variation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinesins; Polymorphism, Genetic; Risk Factors | 2018 |
L-Arginine and vascular health.
Topics: Animals; Arginine; Atherosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase; Signal Transduction | 2016 |
Asymmetric dimethylarginine and angiogenesis: biological significance.
Topics: Animals; Arginine; Atherosclerosis; Cardiovascular Diseases; Endothelial Cells; Humans; Neovascularization, Pathologic; Neovascularization, Physiologic; Plaque, Atherosclerotic; Signal Transduction; Up-Regulation | 2018 |
Association of l-Arginine Supplementation with Markers of Endothelial Function in Patients with Cardiovascular or Metabolic Disorders: A Systematic Review and Meta-Analysis.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Dietary Supplements; Endothelium, Vascular; Female; Humans; Hyperemia; Male; Middle Aged; Nitrates; Nitrites; Obesity; Treatment Outcome | 2018 |
Genetic regulation of dimethylarginines and endothelial dysfunction in rheumatoid arthritis.
Topics: Arginine; Arthritis, Rheumatoid; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Endothelium, Vascular; Humans; Inflammation; Nitric Oxide; Nitric Oxide Synthase; Polymorphism, Single Nucleotide; Transaminases | 2019 |
PRMTs and miRNAs: functional cooperation in cancer and beyond.
Topics: 3' Untranslated Regions; Arginine; Cardiovascular Diseases; Epigenesis, Genetic; Histones; Humans; Inflammation; Methylation; MicroRNAs; Neoplasms; Neurodegenerative Diseases; Peptide Chain Initiation, Translational; Protein Binding; Protein-Arginine N-Methyltransferases | 2019 |
Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach.
Topics: Aging; Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Metabolic Networks and Pathways; Molecular Targeted Therapy; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic | 2019 |
Asymmetric and symmetric dimethylarginine concentration as an indicator of cardiovascular diseases in rheumatoid arthritis patients: a systematic review and meta-analysis of case-control studies.
Topics: Arginine; Arthritis, Rheumatoid; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Comorbidity; Endothelium, Vascular; Humans; Risk Factors | 2020 |
Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
Topics: Animals; Arginase; Arginine; Cardiovascular Agents; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress | 2013 |
Asymmetric Dimethylarginine (ADMA): a promising biomarker for cardiovascular disease?
Topics: Aging; Amidohydrolases; Arginine; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Chromatography, High Pressure Liquid; Diabetes Complications; Enzyme-Linked Immunosorbent Assay; Humans; Hypertension; Mass Spectrometry; Nitric Oxide; Oxidative Stress; Reference Values; Risk Factors; Smoking | 2013 |
Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects.
Topics: Adipose Tissue; Arginine; Biological Transport; Biopterins; Cardiovascular Diseases; Cardiovascular System; Citrulline; Diet; Dietary Supplements; Humans; Nitric Oxide Synthase | 2014 |
Genome-wide association study identifies 3 genomic loci significantly associated with serum levels of homoarginine: the AtheroRemo Consortium.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Chromosomes, Human; Enzymes; Female; Genetic Loci; Genome-Wide Association Study; Genotype; Homoarginine; Humans; Male; Middle Aged; Mitochondria; Polymorphism, Single Nucleotide | 2013 |
Is asymmetric dimethylarginine associated with being born small and large for gestational age?
Topics: Arginine; Biomarkers; Birth Weight; Cardiovascular Diseases; Female; Gestational Age; Humans; Metabolic Diseases; Pregnancy | 2014 |
Dimethylarginines ADMA and SDMA: the real water-soluble small toxins?
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Humans; Kidney Diseases; Water | 2014 |
L-Arginine and its metabolites in kidney and cardiovascular disease.
Topics: Animals; Arginase; Arginine; Biomarkers; Carboxy-Lyases; Cardiovascular Diseases; Dietary Supplements; Endothelium, Vascular; Evidence-Based Medicine; Humans; Isoenzymes; Kidney; Models, Biological; Nitric Oxide Synthase | 2014 |
Asymmetric Dimethylarginine (ADMA) in cardiovascular and renal disease.
Topics: Arginine; Cardiovascular Diseases; Humans; Kidney Diseases; Kidney Transplantation; Nitric Oxide; Nitric Oxide Synthase; Proteinuria | 2015 |
Does elevated asymmetrical dimethylarginine predict major adverse cardiac events and mortality in patients after percutaneous coronary intervention?
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Humans; Mortality; Percutaneous Coronary Intervention; Prospective Studies | 2015 |
Nitrergic system and plasmatic methylarginines: Evidence of their role in the perinatal programming of cardiovascular diseases.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Female; Humans; Nitric Oxide; Pregnancy | 2015 |
Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies.
Topics: Arginine; Cardiovascular Diseases; Humans; Odds Ratio; Prospective Studies; Stroke | 2015 |
Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches.
Topics: Alzheimer Disease; Animals; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Hypercholesterolemia; Neoplasms; Pre-Eclampsia; Pregnancy; Renal Insufficiency, Chronic | 2015 |
Benefits of L-Arginine on Cardiovascular System.
Topics: Animals; Arginine; Cardiovascular Diseases; Humans; Nitric Oxide | 2016 |
Vascular nitric oxide: Beyond eNOS.
Topics: Animals; Arginine; Cardiovascular Diseases; Cell Physiological Phenomena; Cyclic GMP; Endothelium, Vascular; Guanylate Cyclase; Humans; Muscle Contraction; Muscle Tonus; Muscle, Smooth, Vascular; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrites; S-Nitrosothiols; Signal Transduction | 2015 |
The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise.
Topics: Arginine; Biological Availability; Biological Transport; Cardiovascular Diseases; Disease Progression; Endothelium, Vascular; Exercise; Humans; Nitric Oxide; Oxidative Stress; Renal Insufficiency, Chronic; Risk Factors | 2016 |
Diet in children with phenylketonuria and risk of cardiovascular disease: A narrative overview.
Topics: Adiponectin; Arginine; Blood Pressure; Cardiovascular Diseases; Child; Cholesterol, HDL; Cholesterol, LDL; Diet; Homocysteine; Humans; Oxidative Stress; Pediatric Obesity; Phenylalanine; Phenylketonurias; Risk Factors | 2016 |
[Asymmetric dimethylarginine: predictor of cardiovascular diseases?].
Topics: Arginine; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide Synthase; Predictive Value of Tests; Risk Assessment; Risk Factors | 2016 |
Reversal of Newer Direct Oral Anticoagulant Drugs (DOACs).
Topics: Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic Agents; Arginine; Blood Coagulation; Blood Coagulation Factors; Cardiovascular Diseases; Dabigatran; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Models, Molecular; Piperazines; Recombinant Proteins | 2017 |
Safety and performance benefits of arginine supplements for military personnel: a systematic review.
Topics: Arginine; Athletic Performance; Caffeine; Cardiovascular Diseases; Creatine; Dietary Supplements; Gastrointestinal Diseases; Humans; Military Personnel | 2016 |
Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Humans; Prospective Studies; Risk Factors | 2016 |
The story of protein arginine methylation: characterization, regulation, and function.
Topics: Arginine; Cardiovascular Diseases; DNA Repair; Humans; Mass Spectrometry; Methylation; Multiple Sclerosis; Muscular Atrophy, Spinal; Neoplasms; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Proteins; Proteomics; Signal Transduction | 2017 |
Oxidative Stress and Cardiovascular Aging: Interaction Between NRF-2 and ADMA.
Topics: Aging; Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction | 2017 |
Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Humans; Nitric Oxide; Nitric Oxide Synthase; Proportional Hazards Models; Renal Dialysis; Risk Factors | 2017 |
Protein arginine methylation in health and disease.
Topics: Animals; Arginine; Autoimmune Diseases; Cardiovascular Diseases; Humans; Methylation; Models, Biological; Neoplasms; Virus Diseases | 2008 |
[Asymmetric dimethylarginine as cardiovascular risk factor].
Topics: Arginine; Cardiovascular Diseases; Humans; Risk Factors | 2008 |
Cardiovascular disease in patients with diabetic nephropathy.
Topics: Anemia; Arginine; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Enzyme Inhibitors; Glycation End Products, Advanced; Homocysteine; Humans; Prognosis; Risk Factors | 2008 |
[Endothelial injury and CKD].
Topics: Animals; Arginine; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Humans; Kidney Diseases; Kidney Failure, Chronic; Nitric Oxide; Risk Factors | 2008 |
[Asymmetric dimethylarginine (ADMA): A cardiovascular risk factor].
Topics: Adult; Arginine; Austria; Biomarkers; Cardiovascular Diseases; Humans; Male; Prevalence; Risk Assessment; Risk Factors | 2008 |
[Novelties in the field of progression factors in chronic kidney disease].
Topics: Adult; Amidohydrolases; Animals; Arginine; Carbon; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Disease Progression; Female; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infant, Low Birth Weight; Infant, Newborn; Kidney Diseases; Male; Oxides; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Uremia; Uric Acid | 2008 |
ADMA, cardiovascular disease and diabetes.
Topics: Arginine; Cardiovascular Diseases; Diabetes Mellitus; Humans; Models, Biological | 2008 |
Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Adult; Aged; Arginine; Brachial Artery; Cardiovascular Diseases; Child; Endothelium, Vascular; Fasting; Female; Humans; Male; Middle Aged; Pulsatile Flow; Randomized Controlled Trials as Topic; Regional Blood Flow; Time Factors; Vascular Resistance; Vasodilation; Young Adult | 2009 |
Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Agents; Cardiovascular Diseases; Disease Progression; Drug Delivery Systems; Gene Expression Regulation, Enzymologic; Humans; Nitric Oxide | 2009 |
Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.
Topics: Animals; Arginine; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Kidney; Nitric Oxide Synthase; Risk Factors | 2009 |
The use of surrogate vascular markers in youth at risk for premature cardiovascular disease.
Topics: Adolescent; Age of Onset; Arginine; Biomarkers; Blood Flow Velocity; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Cell Adhesion Molecules; Child; Humans; Risk Factors; Time Factors; Tunica Intima; Ultrasonography | 2009 |
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality--an update on patient populations with a wide range of cardiovascular risk.
Topics: Animals; Arginine; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Prospective Studies; Risk Factors | 2009 |
Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production.
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Protein-Arginine N-Methyltransferases | 2009 |
Cellular ADMA: regulation and action.
Topics: Animals; Arginine; Cardiovascular Diseases; Endothelial Cells; Humans; Nitric Oxide Synthase; Signal Transduction | 2009 |
The emerging role of symmetric dimethylarginine in vascular disease.
Topics: Arginine; Cardiovascular Diseases; Homeostasis; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Renal Insufficiency | 2009 |
The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine.
Topics: Amidohydrolases; Animals; Arginine; Biochemistry; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Metabolic Clearance Rate; Models, Biological; Nitric Oxide Synthase; Oxidative Stress; Prognosis | 2010 |
L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging.
Topics: Aging; Anti-Inflammatory Agents; Arginine; Cardiovascular Diseases; Endothelial Cells; Humans; Nitric Oxide; Nutritional Physiological Phenomena; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Nitric oxide and oxidative stress in vascular disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Arginine; Aryldialkylphosphatase; Biopterins; Calcium; Cardiovascular Diseases; Catalase; Electron Transport; Glutathione Peroxidase; Heme Oxygenase (Decyclizing); Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mitochondria; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Protein Multimerization; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Superoxide Dismutase; Superoxides; Thioredoxins; Vascular Diseases; Xanthine Oxidase | 2010 |
Is oxidative stress a therapeutic target in cardiovascular disease?
Topics: Antioxidants; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Mitochondria; NADPH Oxidases; Nitric Oxide Synthase; Oxidative Stress; Polyphenols; Prognosis; Prospective Studies; Reactive Oxygen Species; Risk Factors; Vitamins; Xanthine Oxidase | 2010 |
The biology and therapeutic potential of the DDAH/ADMA pathway.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Molecular Targeted Therapy; Nitric Oxide; Nitric Oxide Synthase | 2010 |
Novel endothelial biomarkers: implications for periodontal disease and CVD.
Topics: Animals; Arginine; Biomarkers; Cardiovascular Diseases; Cell-Derived Microparticles; Endothelial Cells; Endothelium, Vascular; Gingivitis; Humans; Nitric Oxide Synthase; Periodontitis; Stem Cells | 2011 |
Asymmetric dimethylarginine: clinical applications in pediatric medicine.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Child, Preschool; Endothelium, Vascular; Enzyme Inhibitors; Humans; Infant; Nitric Oxide Synthase; Pediatrics; Reference Values; Risk Factors | 2011 |
Measurement of in vivo nitric oxide synthesis in humans using stable isotopic methods: a systematic review.
Topics: Age Factors; Arginine; Arteries; Cardiovascular Diseases; Citrulline; Clinical Laboratory Techniques; Humans; Nitrates; Nitric Oxide; Oxygen; Radioisotopes; Reproducibility of Results; Vasodilation | 2011 |
Nitric oxide synthases: regulation and function.
Topics: Animals; Arginine; Biopterins; Cardiovascular Agents; Cardiovascular Diseases; Endothelium, Vascular; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoenzymes; Mice; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III | 2012 |
Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and *NO bioavailability: Potential benefits to cardiovascular diseases.
Topics: Animals; Antioxidants; Arginine; Biological Availability; Cardiovascular Diseases; Diet, Atherogenic; Endothelium, Vascular; Fatty Acids; Humans; Mice; Nitric Oxide; Oxidative Stress; Polyphenols; Rabbits; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes; Wine | 2012 |
AGEs and cardiovascular diseases in patients with end-stage renal diseases.
Topics: Arginine; Atherosclerosis; Cardiovascular Diseases; Female; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Lysine; Male; Oxidative Stress; Renal Dialysis; Risk Factors; Serum Albumin; Vascular Stiffness | 2012 |
Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables.
Topics: Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Vascular; Humans; Kidney Diseases; Rats; Reactive Oxygen Species; Risk Factors | 2012 |
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
Topics: Amidohydrolases; Animals; Arginine; Binding Sites; Binding, Competitive; Biomarkers; Cardiovascular Agents; Cardiovascular Diseases; Catalytic Domain; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine | 2012 |
[Methylarginies-induced endothelial dysfunction in chronic kidney disease].
Topics: Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Renal Insufficiency, Chronic; Risk Factors | 2012 |
New directions in cardiovascular risk assessment: the role of secondary risk stratification markers.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adrenomedullin; Ankle Brachial Index; Arginine; Biomarkers; Blood Flow Velocity; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Early Diagnosis; Humans; Lipoprotein(a); Natriuretic Peptide, Brain; Peptide Fragments; Protein Precursors; Risk Assessment; Troponin; Vascular Calcification; Vasodilation | 2012 |
Citrulline: from metabolism to therapeutic use.
Topics: Aging; Animals; Arginine; Biological Transport; Cardiovascular Diseases; Citrulline; Humans; Intestinal Mucosa; Models, Animal; Muscle, Skeletal; Protein Biosynthesis; Sarcopenia | 2013 |
Cardiovascular risk in autoimmune disorders: role of asymmetric dimethylarginine.
Topics: Animals; Arginine; Autoimmune Diseases; Cardiovascular Diseases; Humans; Risk | 2012 |
Asymmetric dimethylarginine, endothelial dysfunction and renal disease.
Topics: Adult; Amidohydrolases; Arginine; Biomarkers; Cardiovascular Diseases; Child; Disease Progression; Endothelial Cells; Endothelium, Vascular; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Nitric Oxide; Oxidative Stress; Risk Factors | 2012 |
L-arginine, tetrahydrobiopterin, nitric oxide and diabetes.
Topics: Arginine; Biomarkers; Biopterins; Cardiovascular Diseases; Diabetes Mellitus; Endothelium, Vascular; Homeostasis; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Tetrahydrofolate Dehydrogenase | 2013 |
Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase; Rheumatic Diseases; Risk Factors | 2012 |
Beta blockers, nitric oxide, and cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Arginine; Cardiovascular Diseases; Humans; Nitric Oxide; Vasodilation | 2013 |
Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?
Topics: Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Metabolic Syndrome | 2002 |
Arginine: Clinical potential of a semi-essential amino acid..
Topics: Animals; Arginine; Cardiovascular Diseases; Dietary Supplements; Growth Hormone; HIV Wasting Syndrome; Humans; Infertility; Rats; Sexual Dysfunction, Physiological | 2002 |
L-arginine in cardiovascular disease: dream or reality?
Topics: Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress | 2002 |
[Cardiovascular events in chronic advanced renal insufficiency. Current concepts].
Topics: Anemia; Arginine; C-Reactive Protein; Cardiovascular Diseases; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Inflammation; Kidney Failure, Chronic; Nitric Oxide Synthase; Risk Factors; Sleep Apnea Syndromes; Smoking | 2003 |
Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
Topics: Arginine; Cardiovascular Diseases; Humans; Kidney Diseases; Risk Factors | 2003 |
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
Topics: Amidohydrolases; Arginine; Biomarkers; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide Synthase; Risk Factors | 2003 |
Association of asymmetric dimethylarginine and endothelial dysfunction.
Topics: Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide Synthase | 2003 |
ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Kidney Failure, Chronic; Nitric Oxide Synthase; Risk Factors | 2003 |
ADMA and oxidative stress.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide Synthase; Oxidative Stress; Vasodilation | 2003 |
NO and angiogenesis.
Topics: Angiogenesis Inhibitors; Arginine; Cardiovascular Diseases; Cell Movement; Cell Survival; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide | 2003 |
Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.
Topics: Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hyperhomocysteinemia; Risk Factors | 2003 |
Novel cardiovascular risk factors in end-stage renal disease.
Topics: Arginine; Calcinosis; Cardiovascular Diseases; Humans; Hypertension; Inflammation; Kidney Failure, Chronic; Nitric Oxide Synthase; Oxidative Stress; Risk Factors | 2004 |
Asymmetric dimethylarginine (ADMA) modulates endothelial function--therapeutic implications.
Topics: Animals; Arginine; Cardiovascular Diseases; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nitric Oxide Synthase; Up-Regulation | 2003 |
[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cells, Cultured; Child; Coronary Disease; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Free Radicals; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Nitric Oxide Synthase; Oxidative Stress; Pre-Eclampsia; Pregnancy; Prospective Studies; Rabbits; Regression Analysis; Renal Dialysis; Risk Factors; Stroke | 2004 |
Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Diabetes Mellitus; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Mice; Models, Biological; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pre-Eclampsia; Pregnancy; Protein-Arginine N-Methyltransferases; Renal Insufficiency | 2004 |
The pivotal role of nitric oxide for vascular health.
Topics: Arginine; Arteriosclerosis; Cardiovascular Diseases; Disease Progression; Endothelium, Vascular; Female; Homeostasis; Humans; Male; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity; Survival Analysis | 2004 |
Cardiovascular diseases and the nitric oxide pathway.
Topics: Animals; Arginine; Arteriosclerosis; Cardiovascular Diseases; Cardiovascular System; Diabetes Mellitus; Humans; Hypertension; Nitric Oxide; Nitric Oxide Synthase; Shock, Septic | 2003 |
Hypercholesterolemia and endothelium dysfunction: role of dietary supplementation as vascular protective agents.
Topics: Animals; Antioxidants; Arginine; Arteriosclerosis; Cardiovascular Diseases; Dietary Supplements; Endothelium, Vascular; Fatty Acids, Omega-3; Flavonoids; Humans; Hypercholesterolemia; Isoflavones; Phytoestrogens; Plant Preparations; Vitamins | 2004 |
Asymmetric dimethylarginine (ADMA) and acute vascular events.
Topics: Acute Disease; Angina Pectoris; Arginine; Cardiovascular Diseases; Humans; Myocardial Infarction; Stroke | 2004 |
Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor.
Topics: Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide Synthase; Risk Factors | 2004 |
Arginine and endothelial and vascular health.
Topics: Animals; Arginine; Blood Vessels; Cardiovascular Diseases; Endothelium, Vascular; Humans | 2004 |
[Asymmetric dimethylarginine and endothelial dysfunction].
Topics: Amidohydrolases; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Hemodynamics; Humans; Methylation; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Renin-Angiotensin System | 2004 |
Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
Topics: Ancrod; Antibodies; Anticoagulants; Arginine; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Practice Guidelines as Topic; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Sulfonamides; Thrombin | 2005 |
Kidney disease as an independent risk factor for cardiovascular events.
Topics: Arginine; Cardiovascular Diseases; Humans; Hyperhomocysteinemia; Inflammation; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Lipoproteins; Lipoproteins, LDL; Nitric Oxide Synthase; Oxidative Stress; Proteinuria; Renal Dialysis; Risk Factors | 2005 |
L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
Topics: Arginine; Arteriosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III | 2005 |
Endothelial cell dysfunction: the syndrome in making.
Topics: Animals; Apoptosis; Arginine; Cardiovascular Diseases; Cellular Senescence; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Hyperhomocysteinemia; Kidney Diseases; Models, Biological; Oxidative Stress; Syndrome | 2005 |
[L-arginin-nitric oxide system in the therapy of diseases of the heart and vessels].
Topics: Animals; Arginine; Cardiovascular Diseases; Humans; Nitric Oxide; Oxidative Stress; Treatment Outcome | 2005 |
Clinical epidemiology of major nontraditional risk factors in peritoneal dialysis patients.
Topics: Arginine; Autonomic Nervous System Diseases; C-Reactive Protein; Cardiovascular Diseases; Humans; Hyperhomocysteinemia; Inflammation; Italy; Kidney Failure, Chronic; Nitric Oxide Synthase; Norepinephrine; Peritoneal Dialysis; Risk Factors | 2005 |
Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Carotid Arteries; Carotid Stenosis; Cross-Sectional Studies; Endocrine System Diseases; Endothelium, Vascular; Haplorhini; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Nitric Oxide; Rats; Rats, Inbred Dahl; Renal Dialysis; Risk Factors; Sodium Chloride, Dietary; Tunica Intima; Tunica Media; Uremia | 2005 |
Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality.
Topics: Animals; Arginine; Biomarkers; Cardiovascular Diseases; Endothelial Cells; Humans; Nitric Oxide; Prognosis | 2005 |
Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance.
Topics: Animals; Arginine; Cardiovascular Diseases; Homocysteine; Humans; Risk Factors; Sensitivity and Specificity | 2005 |
[Molecular mechanisms of dysfunction of vascular endothelium].
Topics: Adult; Animals; Apoptosis; Arginine; Atherosclerosis; Cardiovascular Diseases; Cells, Cultured; Child; Endothelial Cells; Endothelin-1; Endothelium, Vascular; Epoprostenol; Female; GTP-Binding Proteins; Hemodynamics; Humans; Macrophages; Male; Multienzyme Complexes; Mutation; NADH, NADPH Oxidoreductases; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Pregnancy; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Risk Factors; RNA, Messenger | 2005 |
[L-arginine: an amino acid with multiple effects].
Topics: Arginine; Asthma; Body Constitution; Cardiovascular Diseases; Dietary Supplements; Fracture Healing; Humans; Neoplasms | 2005 |
ADMA: its role in vascular disease.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Mice; Mice, Transgenic; Models, Animal; Nitric Oxide; Nitric Oxide Synthase; Risk Factors | 2005 |
Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Vasodilation | 2005 |
ADMA and hyperhomocysteinemia.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Homocysteine; Humans; Hyperhomocysteinemia; Nitric Oxide; Nitric Oxide Synthase Type III; Risk Factors; Superoxides; Vasodilation | 2005 |
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
Topics: Animals; Arginine; Cardiovascular Diseases; Drug Evaluation, Preclinical; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metabolic Syndrome; Nitric Oxide; Nitric Oxide Synthase; Randomized Controlled Trials as Topic; Risk Factors; Vasodilation | 2005 |
DDAH gene and cardiovascular risk.
Topics: Amidohydrolases; Arginine; Cardiovascular Diseases; Humans; Hypertension; Male; Mutation; Polymorphism, Genetic; Risk Factors | 2005 |
Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
Topics: Amidohydrolases; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Nitric Oxide; Nitric Oxide Synthase; Protein-Arginine N-Methyltransferases; Renal Insufficiency | 2005 |
Arginine metabolism in vascular biology and disease.
Topics: Animals; Arginase; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Erythrocytes; Humans; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase | 2005 |
Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Drug Administration Schedule; Factor Xa Inhibitors; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia | 2006 |
[The best of epidemiology and cardiovascular prevention in 2005].
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Complications; Environmental Pollutants; Humans; Metabolic Syndrome; Publishing; Risk Factors; Smoking | 2006 |
Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move.
Topics: Arginine; Cardiovascular Diseases; Humans; Renal Insufficiency; Risk Factors | 2006 |
Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond.
Topics: Arginine; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Endothelium, Vascular; Female; Humans; Hyperthyroidism; Insulin Resistance; Liver Failure; Male; Metabolic Syndrome; Nitric Oxide; Nitric Oxide Synthase; Pre-Eclampsia; Pregnancy; Risk Factors; Stereoisomerism | 2006 |
[Uraemic toxins and cardiovascular diseases].
Topics: Arginine; Cardiovascular Diseases; Glycosylation; Homocysteine; Humans; Uremia | 2005 |
Clinical methods for the evaluation of endothelial function-- a focus on resistance arteries.
Topics: Acetylcholine; Adipose Tissue; Adrenergic beta-Agonists; Arginine; Arteries; Biomarkers; Blood Flow Velocity; Cardiovascular Diseases; Endothelium, Vascular; Forearm; Humans; Hyperemia; Laser-Doppler Flowmetry; Myography; Nitric Oxide; Plethysmography; Regional Blood Flow; Skin; Ultrasonography; Vascular Resistance; Vasodilator Agents; Vasomotor System | 2006 |
[Asymmetric dimethylarginine--a novel cardiovascular risk factor].
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus; Endothelium, Vascular; Humans; Kidney Failure, Chronic; Nitric Oxide; Nitric Oxide Synthase; Vasodilation | 2006 |
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Creatinine; Female; Humans; Inulin; Male; Prognosis; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors | 2006 |
[The importance of regulation of endogenous methylarginine concentrations in clinical practice].
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Protein-Arginine N-Methyltransferases | 2005 |
Heparin-induced thrombocytopenia and cardiovascular diseases.
Topics: Anticoagulants; Arginine; Cardiac Surgical Procedures; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sensitivity and Specificity; Sulfonamides; Thrombocytopenia; Thrombosis | 2006 |
The clinical significance of asymmetric dimethylarginine.
Topics: Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Kidney; Liver; Nitric Oxide; Nitric Oxide Synthase; Risk Factors | 2006 |
[Nitric oxide].
Topics: Adiponectin; Aldosterone; Animals; Arginine; Blood Pressure; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertension; Nitric Oxide; Nitric Oxide Synthase Type III; Stem Cells; Stress, Mechanical | 2006 |
Arginine, arginine analogs and nitric oxide production in chronic kidney disease.
Topics: Absorption; Amidohydrolases; Arginine; Biological Availability; Cardiovascular Diseases; Chronic Disease; Comorbidity; Enzyme Inhibitors; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Nitric Oxide; Nitric Oxide Synthase; Polymorphism, Genetic | 2006 |
Nutrition, physical activity, and cardiovascular disease: an update.
Topics: Antioxidants; Arginine; Cardiovascular Diseases; Diet; Exercise; Fruit; Humans; Life Style; Myocardium; Nitric Oxide; Oxidative Stress; Vegetables | 2007 |
Aspects of nitric oxide in health and disease: a focus on hypertension and cardiovascular disease.
Topics: Acetylcholine; Arginine; Black or African American; Blood Pressure; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertension; Infusions, Intravenous; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Vasodilation; Vasodilator Agents | 2006 |
Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor--evidence from epidemiological and prospective clinical trials.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Cross-Sectional Studies; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase; Prospective Studies; Risk Factors | 2006 |
Nitric oxide, malnutrition and chronic renal failure.
Topics: Arginine; Cardiovascular Diseases; Humans; Kidney Failure, Chronic; Malnutrition; Nitric Oxide | 2007 |
The past, presence and future of ADMA in nephrology.
Topics: Arginine; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Kidney Diseases; Kidney Function Tests; Nitric Oxide Synthase; Risk Factors | 2007 |
The pharmacodynamics of L-arginine.
Topics: Arginine; Cardiovascular Diseases; Humans; Nitric Oxide | 2007 |
C-reactive protein and asymmetric dimethylarginine: markers or mediators in cardiovascular disorders?
Topics: Animals; Arginine; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Humans; Inflammation; Nitric Oxide; Risk Assessment; Risk Factors | 2007 |
Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.
Topics: Arginine; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Humans; Kidney Diseases; Nitric Oxide; Nitric Oxide Synthase | 2007 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarkers; Bone Resorption; Calcinosis; Calcium; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Cohort Studies; Creatinine; Cystatin C; Cystatins; Diabetes Complications; Disease Progression; Dogs; Dyslipidemias; Endothelium, Vascular; Glomerular Filtration Rate; Humans; Hypertension, Renal; Inflammation Mediators; Kidney Diseases; Oxidative Stress; Phosphates; Renin-Angiotensin System; Risk Factors | 2007 |
Arginase: a critical regulator of nitric oxide synthesis and vascular function.
Topics: Animals; Arginase; Arginine; Cardiovascular Diseases; Cell Proliferation; Collagen; Endothelium, Vascular; Homeostasis; Humans; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase Type III; Reactive Oxygen Species; Urea | 2007 |
L-arginine transporters in cardiovascular disease: a novel therapeutic target.
Topics: Amino Acid Transport Systems, Basic; Animals; Arginine; Biological Transport; Cardiovascular Diseases; Humans; Kinetics; Nitric Oxide | 2007 |
Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; Kidney; Kidney Diseases; Liver Diseases; Nitric Oxide; Nitric Oxide Synthase; Vasodilation | 2007 |
Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease.
Topics: Arginine; Cardiovascular Diseases; Humans; Kidney Failure, Chronic | 2007 |
L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
Topics: Arginine; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Nitric Oxide; Nitric Oxide Synthase | 2008 |
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
Topics: Albuminuria; Arginine; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Humans; Kidney Diseases; Ossification, Heterotopic; Oxidative Stress; Risk Assessment; Uremia | 2008 |
Depression and cardiovascular disease: role of nitric oxide.
Topics: Animals; Arginine; Cardiovascular Diseases; Depression; Disease Models, Animal; Humans; Nitric Oxide; Risk Factors; Signal Transduction | 2008 |
[Nitric oxide: an intercellular gas with physiological and toxic actions. New perspectives].
Topics: Arginine; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Central Nervous System; Feedback; Humans; Muscle, Smooth, Vascular; Nitric Oxide; Oxidation-Reduction | 1994 |
[Nitric oxide. Current findings on the synthesis and genetics of nitric oxide synthases, regulation of hypothalamic and vascular function].
Topics: Arginine; Brain; Cardiovascular Diseases; Cell Communication; Corticotropin-Releasing Hormone; Endothelium, Vascular; Growth Hormone; Humans; Hypothalamus; Luteinizing Hormone; Nitric Oxide; Nitric Oxide Synthase | 1995 |
Why are lipids not predictive of cardiovascular death in the dialysis patient?
Topics: Apolipoproteins B; Arginine; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Heart Diseases; Humans; Lipoprotein(a); Nutrition Disorders; Predictive Value of Tests; Renal Dialysis; Risk Assessment; Survival Rate | 1996 |
Maintenance of vascular integrity: role of nitric oxide and other bradykinin mediators.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Blood Vessels; Bradykinin; Cardiovascular Diseases; Endothelium, Vascular; Homeostasis; Humans; Nitric Oxide | 1995 |
[The L-arginine-nitric oxide system: physiology, physiopathology and clinical relevance].
Topics: Animals; Arginine; Arteriosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Endothelium; Humans; Hypertension; Nervous System Diseases; Nitric Oxide; Nitric Oxide Synthase; Rats; Shock, Septic | 1997 |
Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases.
Topics: Animals; Arginine; Cardiovascular Diseases; Humans; Nitric Oxide Synthase; Signal Transduction | 1997 |
Role of vascular nitric oxide in physiological and pathological conditions.
Topics: Animals; Arginine; Arteriosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Endothelium, Vascular; Humans; Hypertension; Nitric Oxide; Nitric Oxide Synthase | 1997 |
Cardiovascular effects of L-arginine.
Topics: Animals; Arginine; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Humans | 1998 |
Development of argatroban, a direct thrombin inhibitor, and its clinical application.
Topics: Anticoagulants; Antithrombins; Arginine; Cardiovascular Diseases; Drug Monitoring; Humans; Ischemic Attack, Transient; Molecular Weight; Pipecolic Acids; Sulfonamides | 1997 |
Cholesterol, endothelial function and cardiovascular disease.
Topics: Animals; Antioxidants; Arginine; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Endothelium, Vascular; Fish Oils; Humans; Hypercholesterolemia; Risk Factors | 1998 |
Endothelial function in health and disease: new insights into the genesis of cardiovascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Estrogens; Humans; Nitric Oxide | 1998 |
Nutriceuticals for cardiovascular health.
Topics: Antioxidants; Arginine; Cardiovascular Diseases; Dietary Supplements; Female; Flavonoids; Humans; Male; Middle Aged | 1998 |
L-Arginine: rediscovery in progress.
Topics: Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase; Risk Factors | 1998 |
Role of arginine, taurine and homocysteine in cardiovascular diseases.
Topics: Animals; Arginine; Biomarkers; Cardiovascular Diseases; Homocysteine; Humans; Prognosis; Risk Assessment; Risk Factors; Sensitivity and Specificity; Taurine | 1999 |
Positive and negative outcomes of L-arginine therapy in cardiovascular diseases.
Topics: Arginine; Arterial Occlusive Diseases; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Heart Failure; Humans; Hyperlipidemias; Myocardial Ischemia; Nitric Oxide; Treatment Outcome | 1999 |
Nutritional strategies in cardiovascular disease control: an update on vitamins and conditionally essential nutrients.
Topics: Antioxidants; Arginine; Ascorbic Acid; Cardiovascular Diseases; Carnitine; Coenzymes; Cost-Benefit Analysis; Free Radical Scavengers; Humans; Nutritional Requirements; Primary Prevention; Ubiquinone; Vitamin B Complex; Vitamin E | 1999 |
Arginine nutrition and cardiovascular function.
Topics: Aging; Animals; Arginine; Cardiovascular Diseases; Humans; Nitric Oxide; Nutritional Physiological Phenomena | 2000 |
Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
Topics: Animals; Arginine; Arteriosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide Synthase | 2000 |
Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases.
Topics: Animals; Arginine; Biomarkers; Cardiovascular Diseases; Carrier Proteins; Endothelium, Vascular; Humans; Nitric Oxide; Risk Factors; Ubiquitin-Protein Ligases; Vasodilation | 2001 |
Endothelial function and nitric oxide: clinical relevance.
Topics: Arginine; Cardiovascular Diseases; Coronary Disease; Endothelium, Vascular; Genetic Therapy; Humans; Nitric Oxide; omega-N-Methylarginine; Risk Factors; Sepsis; Vasoconstriction | 2001 |
[Mechanism of nitric oxide production in vascular endothelium and the significance as therapeutic target--special reference to the relationship with superoxides].
Topics: Animals; Antioxidants; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Metabolic Diseases; Nitric Oxide; Nitric Oxide Donors; Superoxides | 2000 |
The clinical pharmacology of L-arginine.
Topics: Animals; Arginine; Cardiovascular Diseases; Hemodynamics; Humans; Nitric Oxide | 2001 |
Dietary modulation of endothelial function: implications for cardiovascular disease.
Topics: Antioxidants; Arginine; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diet; Endothelium, Vascular; Epidemiologic Studies; Fatty Acids, Omega-3; Fish Oils; Folic Acid; Humans; MEDLINE; Oxidative Stress; Risk Factors; Vitamin E | 2001 |
Cardiovascular effects of oral pharmacotherapy in erectile dysfunction.
Topics: Arginine; Cardiovascular Diseases; Erectile Dysfunction; Humans; Male; Neurotransmitter Agents; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2000 |
L-arginine in the management of cardiovascular diseases.
Topics: Arginine; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertension; Menopause; Risk Factors; Smoking; Treatment Outcome | 2001 |
Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism.
Topics: Arginine; Cardiovascular Diseases; Exons; Genetic Variation; Humans; Linkage Disequilibrium; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Polymorphism, Genetic | 2001 |
An integrated proposal to explain the epidemic of cardiovascular disease in a developing country. From socioeconomic factors to free radicals.
Topics: Arginine; Cardiovascular Diseases; Colombia; Developing Countries; Humans; Nitric Oxide; Nutritional Physiological Phenomena; Risk Factors; Socioeconomic Factors; United States | 2001 |
Use of alternative pharmacotherapy in management of cardiovascular diseases.
Topics: Antioxidants; Arginine; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Coenzymes; Complementary Therapies; Dietary Supplements; Drug Interactions; Education, Pharmacy, Continuing; Fish Oils; Garlic; Humans; Plant Preparations; Soybean Proteins; Sterols; Ubiquinone | 2002 |
Toxicity of the topoisomerase II inhibitors.
Topics: Antineoplastic Agents; Cardiovascular Diseases; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Epirubicin; Etoposide; Humans; Idarubicin; Leukemia; Middle Aged; Mitoxantrone; Mucositis; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors; Vascular Diseases | 2005 |
32 trial(s) available for arginine and Cardiovascular Diseases
| Article | Year |
|---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study.
Topics: Administration, Oral; Adult; Alanine Transaminase; Arginine; Aspartate Aminotransferases; C-Reactive Protein; Cardiovascular Diseases; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Febuxostat; Female; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Pancytopenia; Placebos; Prospective Studies; Renal Dialysis; Risk Factors; Treatment Outcome; Uric Acid; Xanthine Oxidase | 2017 |
Altered nitric oxide bioavailability contributes to diesel exhaust inhalation-induced cardiovascular dysfunction in man.
Topics: Adult; Air Pollutants; Arginine; Biological Availability; Blood Pressure; Cardiac Output; Cardiovascular Diseases; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Forearm; Hemodynamics; Humans; Inhalation Exposure; Male; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrites; Time Factors; Vascular Resistance; Vascular Stiffness; Vasoconstriction; Vasodilation; Vasodilator Agents; Vehicle Emissions; Young Adult | 2013 |
Lifestyle modification decreases arterial stiffness and plasma asymmetric dimethylarginine level in overweight and obese men.
Topics: Adult; Animals; Ankle Brachial Index; Arginine; Biomarkers; Caloric Restriction; Cardiovascular Diseases; Down-Regulation; Exercise; Humans; Male; Middle Aged; Obesity; Overweight; Pulse Wave Analysis; Risk Reduction Behavior; Time Factors; Treatment Outcome; Vascular Stiffness | 2013 |
Aortic wave velocity: a noninvasive method to measure the stiffness of arteries and the clinical results of supplements that appear to improve arterial stiffness.
Topics: Adult; Aged; Aging; Arginine; Cardiovascular Diseases; Carnosine; Dietary Supplements; Female; Glycation End Products, Advanced; Guanidines; Humans; Male; Middle Aged; Pulse Wave Analysis; Resveratrol; Risk Factors; Stilbenes; Vascular Stiffness | 2013 |
Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastin.
Topics: Adolescent; Anticholesteremic Agents; Arginine; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glycated Hemoglobin; Heptanoic Acids; Homoarginine; Humans; Lipids; Male; Pilot Projects; Pyrroles; Risk Factors; Treatment Outcome | 2015 |
Effects of 6-month supplementation with β-hydroxy-β-methylbutyrate, glutamine and arginine on vascular endothelial function of older adults.
Topics: Aged; Aged, 80 and over; Aging; Arginine; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Fasting; Female; Glutamine; Humans; Male; Tumor Necrosis Factor-alpha; Valerates; Vasodilation | 2016 |
Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Topics: Adult; Arginine; Asymptomatic Diseases; Biomarkers; Biopsy; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Intima-Media Thickness; Chi-Square Distribution; Collagen; Coronary Artery Disease; Diabetes Mellitus, Type 1; Disease Progression; Female; Glycation End Products, Advanced; Glycosylation; Heart Diseases; Humans; Logistic Models; Lysine; Magnetic Resonance Imaging; Male; Multivariate Analysis; Odds Ratio; Pepsin A; Pyruvaldehyde; Risk Factors; Skin; Time Factors; Vascular Calcification; Young Adult | 2015 |
Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase.
Topics: Aged; Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Activation; Female; Humans; Male; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Reactive Oxygen Species; Signal Transduction; Simvastatin | 2016 |
A Slow- Compared with a Fast-Release Form of Oral Arginine Increases Its Utilization for Nitric Oxide Synthesis in Overweight Adults with Cardiometabolic Risk Factors in a Randomized Controlled Study.
Topics: Adolescent; Adult; Arginine; Biological Availability; Cardiovascular Diseases; Cross-Over Studies; Female; Humans; Male; Metabolic Diseases; Middle Aged; Nitric Oxide; Overweight; Risk Factors; Young Adult | 2016 |
l-Arginine Supplementation Alleviates Postprandial Endothelial Dysfunction When Baseline Fasting Plasma Arginine Concentration Is Low: A Randomized Controlled Trial in Healthy Overweight Adults with Cardiometabolic Risk Factors.
Topics: Adult; Arginine; Arteries; Cardiovascular Diseases; Cross-Over Studies; Dietary Supplements; Endothelium, Vascular; Fasting; Female; Humans; Lipids; Male; Manometry; Metabolic Diseases; Middle Aged; Overweight; Postprandial Period; Young Adult | 2016 |
Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
Topics: Arginine; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Morbidity; Prospective Studies; Renal Dialysis | 2017 |
Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.
Topics: Administration, Oral; Aged; Arginine; Cardiovascular Diseases; Coronary Artery Bypass; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Female; Glucose Tolerance Test; Humans; Inflammation; Insulin Resistance; Male; Middle Aged; Placebos | 2009 |
Altering dietary lysine:arginine ratio has little effect on cardiovascular risk factors and vascular reactivity in moderately hypercholesterolemic adults.
Topics: Adiponectin; Aged; Arginine; Blood Vessels; Cardiovascular Diseases; Cholesterol; Cross-Over Studies; Diet; Female; Humans; Hypercholesterolemia; Lysine; Male; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Risk Factors | 2010 |
Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): a double-blind, randomised, factorial design, placebo-controlled trial.
Topics: Adult; Antioxidants; Arginine; Ascorbic Acid; beta Carotene; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Dietary Supplements; Double-Blind Method; Homocysteine; Humans; Male; Middle Aged; Protective Agents; Triglycerides; Vitamin B Complex; Vitamin E | 2010 |
Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis.
Topics: Administration, Oral; Aged; Arginine; Cardiovascular Diseases; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Vitamin B 12; Vitamin B Complex | 2010 |
L-arginine and antioxidant vitamins E and C improve the cardiovascular performance of broiler chickens grown under chronic hypobaric hypoxia.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Arginine; Ascorbic Acid; Cardiovascular Diseases; Diet; Dietary Supplements; Hypoxia; Poultry Diseases; Pressure; Time Factors; Vitamin E | 2010 |
Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Humans; Linear Models; Male; Middle Aged; Mortality; Predictive Value of Tests; Prognosis; Renal Insufficiency; Risk Factors | 2011 |
Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment.
Topics: Adult; Arginine; Body Mass Index; Cardiovascular Diseases; Contraceptives, Oral; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Young Adult | 2011 |
Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Arginine; Cardiovascular Diseases; Diet, Reducing; Dietary Supplements; Double-Blind Method; Fabaceae; Female; Humans; Hypertriglyceridemia; Insulin Resistance; Iran; Middle Aged; Nitric Oxide; Obesity, Abdominal; Risk Factors; Seeds; Selenium; Waist Circumference; Weight Loss | 2012 |
The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome.
Topics: Adult; Arginine; Body Mass Index; Cardiovascular Diseases; Diet; Endothelium, Vascular; Exercise; Exercise Therapy; Female; Humans; Insulin Resistance; Intercellular Adhesion Molecule-1; Overweight; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Risk; Vascular Cell Adhesion Molecule-1 | 2012 |
Increased plasma availability of L-arginine in the postprandial period decreases the postprandial lipemia in older adults.
Topics: Administration, Oral; Aged; Aging; Arginine; Biological Availability; Cardiovascular Diseases; Dietary Fats; Fatty Acids, Nonesterified; Humans; Hyperlipidemias; Infusions, Intravenous; Male; Postprandial Period; Risk Factors; Triglycerides | 2013 |
Relationship between salt intake, nitric oxide and asymmetric dimethylarginine and its relevance to patients with end-stage renal disease.
Topics: Arginine; Blood Pressure; Cardiovascular Diseases; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Renal Dialysis; Risk Factors; Sodium Chloride | 2002 |
Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women.
Topics: Analysis of Variance; Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Middle Aged; Nitric Oxide Synthase; Postmenopause; Protein Isoforms; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Sensitivity and Specificity | 2003 |
Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Isomerism; Middle Aged; Progesterone Congeners; Promegestone; Risk Factors; Spectrometry, Fluorescence | 2003 |
Cerebrovascular reactivity to L-arginine in patients with lacunar infarctions.
Topics: Aged; Arginine; Blood Flow Velocity; Blood Pressure; Brain Infarction; Carbon Dioxide; Cardiovascular Diseases; Case-Control Studies; Cerebral Arteries; Cerebrovascular Circulation; Endothelial Cells; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Risk Factors; Time Factors; Ultrasonography, Doppler, Transcranial | 2006 |
Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus.
Topics: Adult; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Exercise Therapy; Female; Humans; Male; Treatment Outcome | 2005 |
No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk.
Topics: Adolescent; Adult; Arginine; Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Folic Acid; Humans; Hyperhomocysteinemia; Linear Models; Male; Middle Aged; Pyridoxine; Risk Factors; Time Factors; Treatment Failure; Vitamin B Complex | 2006 |
Effects of combined supplementation with B vitamins and antioxidants on plasma levels of asymmetric dimethylarginine (ADMA) in subjects with elevated risk for cardiovascular disease.
Topics: Adult; Aged; Antioxidants; Arginine; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Lipids; Male; Middle Aged; Risk Factors; Vitamin B Complex | 2007 |
Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Arginine; Benzopyrans; Biomarkers; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Ethanolamines; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nebivolol; Prospective Studies; Treatment Outcome; Triglycerides | 2007 |
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Topics: Acute Disease; Adult; Antioxidants; Arginine; Ascorbic Acid; Blood Coagulation; Blood Viscosity; Cardiovascular Diseases; Cross-Over Studies; Endothelium, Vascular; Female; Hemodynamics; Homocysteine; Humans; Male; Methionine; Platelet Aggregation; Risk Factors; Single-Blind Method; Vitamin E | 1999 |
Oral L-arginine administration attenuates postprandial endothelial dysfunction in young healthy males.
Topics: Adult; Arginine; Brachial Artery; Cardiovascular Diseases; Dietary Fats; Dietary Supplements; Endothelium, Vascular; Fasting; Glutathione; Humans; Insulin; Lipids; Male; Postprandial Period; Risk Factors; Time Factors; Ultrasonography; Vasodilation | 2001 |
297 other study(ies) available for arginine and Cardiovascular Diseases
| Article | Year |
|---|---|
Contributions of endothelin-1 and l-arginine to blunted cutaneous microvascular function in young, black women.
Topics: Arginine; Black or African American; Cardiovascular Diseases; Endothelin Receptor Antagonists; Endothelins; Female; Humans; Microvessels; Nitric Oxide; Peptides, Cyclic; Receptors, Endothelin; Vasodilation; Young Adult | 2022 |
Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Humans; Methylamines; Oxides | 2022 |
Design and validation of an LC-MS/MS method for simultaneous quantification of asymmetric dimethylguanidino valeric acid, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma.
Topics: Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Female; Humans; Male; Non-alcoholic Fatty Liver Disease; Tandem Mass Spectrometry | 2022 |
Arginine catabolism metabolites and atrial fibrillation or heart failure risk: 2 case-control studies within the Prevención con Dieta Mediterránea (PREDIMED) trial.
Topics: Arginine; Atrial Fibrillation; Cardiovascular Diseases; Case-Control Studies; Diet, Mediterranean; Heart Failure; Humans; Mediterranea; Risk Factors | 2022 |
The Association Between Uric Acid and Symmetric Dimethylarginine Levels in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis.
Topics: Arginine; Cardiovascular Diseases; Female; Humans; Lactation; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Uric Acid; Young Adult | 2022 |
Response of circulating metabolites to an oral glucose challenge and risk of cardiovascular disease and mortality in the community.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; Deoxycholic Acid; Female; Glucose; Glucuronates; Glutamates; Humans; Inosine; Ketoglutaric Acids; Lysophosphatidylcholines; Male; Phosphatidylcholines; Risk Factors; Triglycerides | 2022 |
Effect of cigarette smoking on serum methylarginine and α-klotho levels.
Topics: Aging, Premature; Arginine; Cardiovascular Diseases; Cardiovascular System; Cigarette Smoking; Humans; omega-N-Methylarginine | 2023 |
Minimalist Nanocomplex with Dual Regulation of Endothelial Function and Inflammation for Targeted Therapy of Inflammatory Vascular Diseases.
Topics: Animals; Arginine; Atherosclerosis; Cardiovascular Diseases; COVID-19; Endothelial Cells; Inflammation; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type III | 2023 |
Biomimetic Antithrombotic Tissue-Engineered Vascular Grafts for Converting Cholesterol and Free Radicals into Nitric Oxide.
Topics: Arginine; Biomimetics; Blood Vessel Prosthesis; Cardiovascular Diseases; Endothelial Cells; Fibrinolytic Agents; Humans; Nitric Oxide | 2023 |
High-throughput quantitation of serological dimethylarginines by LC/MS/MS: Potential cardiovascular biomarkers for rheumatoid arthritis.
Topics: Arginine; Arthritis, Rheumatoid; Biomarkers; Cardiovascular Diseases; Chromatography, Liquid; Cross-Sectional Studies; Humans; Retrospective Studies; Tandem Mass Spectrometry | 2023 |
Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
Topics: Arginine; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Diabetic Nephropathies; Heart Failure; Humans; Renal Insufficiency, Chronic | 2023 |
Plasma arginine metabolites in health and chronic kidney disease.
Topics: Arginine; Cardiovascular Diseases; Citrulline; Humans; Kidney; Renal Insufficiency, Chronic | 2023 |
Aerobic exercise prevents cardiomyocyte damage caused by oxidative stress in early cardiovascular disease by increasing vascularity while L-arginine supplementation prevents it by increasing activation of the enzyme nitric oxide synthase.
Topics: Animals; Arginine; Cardiovascular Diseases; Dietary Supplements; Fructose; Hypertrophy; Insulin; Matrix Metalloproteinase 2; MicroRNAs; Myocytes, Cardiac; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2023 |
Developmental dynamics of homoarginine, ADMA and SDMA plasma levels from birth to adolescence.
Topics: Adolescent; Adult; Arginine; Cardiovascular Diseases; Child; Child, Preschool; Heart; Homoarginine; Humans; Infant; Infant, Newborn; Renal Insufficiency, Chronic | 2023 |
Diurnal Variation of L-Arginine and the Cardiovascular Risk Markers Asymmetric and Symmetric Dimethylarginine and Homoarginine in Rotating Night Shift Workers and Controls.
Topics: Amino Acids; Arginine; Cardiovascular Diseases; Heart Disease Risk Factors; Homoarginine; Humans; Hydrocortisone; Melatonin; Risk Factors | 2023 |
Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS).
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chemokines; Citrulline; Cytokines; Female; Growth Hormone; Humans; Lower Extremity; Male; Metabolomics; Middle Aged; Nitric Oxide; Wounds and Injuries | 2019 |
Racial Differences in Cardiovascular Biomarkers in the General Population.
Topics: Adiponectin; Adult; Albuminuria; Antibodies, Antinuclear; Arginine; Biomarkers; Black or African American; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Homoarginine; Humans; Interleukin-1 Receptor-Like 1 Protein; Leptin; Linear Models; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Osteoprotegerin; Peptide Fragments; Proportional Hazards Models; Receptor for Advanced Glycation End Products; Troponin T; White People | 2019 |
The Association between Nitric Oxide Pathway, Blood Pressure Abnormalities, and Cardiovascular Risk Profile in Pediatric Chronic Kidney Disease.
Topics: Adolescent; Arginine; Biomarkers; Blood Pressure; Cardiovascular Diseases; Child; Child, Preschool; Female; Heart Ventricles; Humans; Male; Nitric Oxide; Prospective Studies; Pulse Wave Analysis; Renal Insufficiency, Chronic; Risk Factors; Severity of Illness Index; Vascular Stiffness | 2019 |
Blueberry anthocyanin‑enriched extract ameliorates transverse aortic constriction‑induced myocardial dysfunction via the DDAH1/ADMA/NO signaling pathway in mice.
Topics: Amidohydrolases; Animals; Anthocyanins; Aortic Valve Stenosis; Apoptosis; Arginine; Blueberry Plants; Cardiovascular Diseases; Disease Models, Animal; Gene Expression Regulation; Humans; Mice; Myocytes, Cardiac; Nitric Oxide; Oxidative Stress; Plant Extracts; Signal Transduction | 2020 |
Cardiovascular risk factors and the concentration of asymmetric dimethylarginine.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Middle Aged; Risk Factors | 2020 |
Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients.
Topics: Adolescent; Adult; Angiopoietin-Like Protein 2; Angiopoietin-like Proteins; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Renal Insufficiency, Chronic; Risk Assessment; Young Adult | 2020 |
Influence of Human Paraoxonase-1 Polymorphism (Q192R) on Serum Levels of Clinical Biomarkers Indicatives of Cardiovascular Diseases Risk in Mexican Women.
Topics: Adult; Arginine; Aryldialkylphosphatase; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Fatty Acid-Binding Proteins; Female; Genetic Predisposition to Disease; Heart Disease Risk Factors; Humans; Male; Mexico; MicroRNAs; Polymorphism, Genetic; Sex Factors | 2020 |
Asymmetric dimethylarginine compartmental behavior during high-flux hemodialysis.
Topics: Adult; Arginine; Cardiovascular Diseases; Creatinine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Tandem Mass Spectrometry; Urea | 2020 |
Gold Nanorod-Based Nanoplatform Catalyzes Constant NO Generation and Protects from Cardiovascular Injury.
Topics: Arginine; Cardiovascular Diseases; Gold; Humans; Hydrogen Peroxide; Nanotubes; Nitric Oxide | 2020 |
Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease.
Topics: Adult; Arginine; Cardiovascular Diseases; End Stage Liver Disease; Heart Disease Risk Factors; Humans; Nitric Oxide; Risk Factors; Severity of Illness Index | 2020 |
Whole-body arginine dimethylation is associated with all-cause mortality in adult renal transplant recipients.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cause of Death; Female; Heart Disease Risk Factors; Humans; Kidney Transplantation; Male; Methylation; Middle Aged; Protein Processing, Post-Translational; Tissue Donors; Transplant Recipients | 2021 |
Profile of new vascular damage biomarkers in middle-aged men with arterial hypertension.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Endothelium, Vascular; Follow-Up Studies; Humans; Hypertension; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Prognosis | 2021 |
Biomarkers representing key aging-related biological pathways are associated with subclinical atherosclerosis and all-cause mortality: The Framingham Study.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Carotid Intima-Media Thickness; Creatinine; Cross-Sectional Studies; Endothelial Cells; Female; Humans; Insulin-Like Growth Factor I; Isoprostanes; Male; Middle Aged; Oxidative Stress; Prospective Studies; Telomere Homeostasis; Telomere Shortening | 2021 |
Is there a link between the prevalence of cardiovascular disease, diabetes, kidney disease, chronic obstructive pulmonary disease and malignancies and the severity of COVID-19 within the BAME population?
Topics: Arginine; Cardiovascular Diseases; Comorbidity; COVID-19; Diabetes Mellitus; Humans; Kidney Diseases; Neoplasms; Prevalence; Pulmonary Disease, Chronic Obstructive; Risk Factors; SARS-CoV-2 | 2021 |
Love is in the hair: arginine methylation of human hair proteins as novel cardiovascular biomarkers.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Hair; Humans; Methylation; Proteomics | 2022 |
Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients: Cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Topics: Aged; Aldosterone; Arginine; Austria; Biomarkers; Cardiovascular Diseases; Cohort Studies; Coronary Angiography; Cross-Sectional Studies; Female; Follow-Up Studies; Germany; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Male; Middle Aged; Mortality; Peroxidase; Predictive Value of Tests; Prevalence; Prospective Studies; Renin-Angiotensin System; Risk Factors | 2017 |
Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chromatography, Liquid; Citrulline; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Ornithine; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Tandem Mass Spectrometry | 2017 |
HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; HIV Infections; Humans; Inflammation; Male; Methylamines; Middle Aged; Risk Factors; Tandem Mass Spectrometry | 2017 |
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Female; Glomerular Filtration Rate; Humans; Lipoproteins, HDL; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; Risk Factors | 2017 |
Asymmetric dimethylarginine and arginine metabolites in women with and without a history of gestational diabetes.
Topics: Adult; Arginine; Cardiovascular Diseases; Diabetes, Gestational; Female; Follow-Up Studies; Glucose Tolerance Test; Humans; Postpartum Period; Pregnancy; Prognosis | 2017 |
Effect of arginine:lysine and glycine:methionine intake ratios on dyslipidemia and selected biomarkers implicated in cardiovascular disease: A study with hypercholesterolemic rats.
Topics: Administration, Oral; Amino Acids; Animals; Arginine; Biomarkers; Body Weight; Cardiovascular Diseases; Dyslipidemias; Glycine; Homocysteine; Hypercholesterolemia; Lipids; Liver; Lysine; Male; Methionine; Nitric Oxide; Organ Size; Rats, Wistar | 2017 |
Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance.
Topics: Aged; Aged, 80 and over; Amidohydrolases; Arginine; Australia; Biomarkers; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Female; Humans; Male; Mass Spectrometry; Middle Aged; Proton Pump Inhibitors; Risk Assessment | 2017 |
Association between vitamin D status and asymmetric dimethylarginine (ADMA) concentration in the Korean elderly population.
Topics: Aged; Aged, 80 and over; Arginine; Asian People; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Middle Aged; Vitamin D; Vitamin D Deficiency | 2017 |
Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
Topics: Adult; Aged; Albuminuria; Arginine; Cardiovascular Diseases; Coronary Disease; Creatinine; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Risk Factors | 2017 |
Decreased serum L-arginine and L-citrulline levels in major depression.
Topics: Adolescent; Adult; Arginine; Cardiovascular Diseases; Citrulline; Depressive Disorder, Major; Female; Humans; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Reference Values; Risk Factors; Young Adult | 2017 |
Influence on serum asymmetric dimethylarginine (ADMA) concentrations of human paraoxonase 1 polymorphism (Q192R) and exposure to polycyclic aromatic hydrocarbons (PAHs) in Mexican women, a gene-environment interaction.
Topics: Adult; Alleles; Arginine; Aryldialkylphosphatase; Biomarkers; Cardiovascular Diseases; Creatinine; Environmental Exposure; Environmental Pollutants; Female; Gene Frequency; Gene-Environment Interaction; Genetic Predisposition to Disease; Genotype; Humans; Mexico; Polycyclic Aromatic Hydrocarbons; Polymorphism, Genetic; Pyrenes; Risk Factors | 2017 |
Asymmetric dimethylarginine and symmetric dimethylarginine prospectively relates to carotid wall thickening in black men: the SABPA study.
Topics: Adult; Arginine; Black People; Cardiovascular Diseases; Carotid Intima-Media Thickness; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; South America; White People | 2017 |
Biocompatible zinc oxide nanocrystals stabilized via hydroxyethyl cellulose for mitigation of diabetic complications.
Topics: Animals; Arginine; Biocompatible Materials; Cardiovascular Diseases; Cellulose; Diabetes Mellitus, Experimental; Humans; Hyperglycemia; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Rats; Zinc Oxide | 2018 |
Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, Liquid; Disease Progression; Female; Germany; Humans; Incidence; Male; Middle Aged; omega-N-Methylarginine; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors | 2018 |
Serum Concentrations of New Predictive Cardiovascular Disease Biomarkers in Mexican Women Exposed to Lead.
Topics: Adiponectin; Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Cardiovascular Diseases; Chemokines; Cross-Sectional Studies; Environmental Exposure; Fatty Acid-Binding Proteins; Female; Humans; Intercellular Signaling Peptides and Proteins; Lead; Male; Mexico; Middle Aged | 2018 |
Experience of correcting endothelial dysfunction in children-residents of radioactively contaminated areas by nitric oxide potential donator citrulline.
Topics: Arginine; Bronchial Spasm; Cardiovascular Diseases; Chernobyl Nuclear Accident; Child; Citrulline; Endothelium, Vascular; Female; Humans; Immunity, Cellular; Immunity, Humoral; Lipid Peroxidation; Malates; Male; Nitric Oxide; Nitric Oxide Donors; Nitrites; Radiation Dosage; Radiation Exposure; Radioactive Pollutants; Rural Population; Survivors; T-Lymphocytes; Ukraine; Urban Population | 2017 |
Increased Endothelial Dysfunction and Insulin Resistance in Patients with Klinefelter Syndrome.
Topics: Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Endothelium, Vascular; Humans; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Klinefelter Syndrome; Male; Multivariate Analysis; Prevalence; Risk Factors; Testosterone; Turkey; Young Adult | 2018 |
Association of endothelial dysfunction with cardiovascular risk factors and new-onset diabetes mellitus in patients with hypertension.
Topics: Aged; Arginine; Brazil; C-Reactive Protein; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Nitric Oxide Synthase; Predictive Value of Tests; Prospective Studies; Risk Factors; Triglycerides | 2018 |
Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction.
Topics: Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Endothelium; Feces; Female; Gastrointestinal Microbiome; HIV Infections; Humans; Inflammation; Kynurenine; Male; Metabolism; Middle Aged; Neopterin; Risk Factors; RNA, Ribosomal, 16S; Tryptophan | 2018 |
Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
Topics: Aged; Arginase; Arginine; Arthritis, Rheumatoid; Biomarkers; Cardiovascular Diseases; Comorbidity; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Prevalence; Risk Factors; United States | 2018 |
Cyclooxygenase-2, Asymmetric Dimethylarginine, and the Cardiovascular Hazard From Nonsteroidal Anti-Inflammatory Drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Blood Pressure; Blood Urea Nitrogen; Cardiovascular Diseases; Celecoxib; Creatinine; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Kidney; Metabolome; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoarthritis; Placebo Effect | 2018 |
Age-dependent effects of homocysteine and dimethylarginines on cardiovascular mortality in claudicant patients with lower extremity arterial disease.
Topics: Aged; Aging; Arginine; Austria; Cardiovascular Diseases; Female; Homocysteine; Humans; Incidence; Intermittent Claudication; Lower Extremity; Male; Prospective Studies; Risk Factors; Survival Rate | 2018 |
Decreased serum level of nitric oxide in children with excessive body weight.
Topics: Adolescent; Arginine; Biomarkers; Body Weight; Cardiovascular Diseases; Case-Control Studies; Child; Child, Preschool; Female; Humans; Male; Nitric Oxide; Obesity | 2019 |
Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cardiovascular System; Female; Homoarginine; Humans; Incidence; Lower Extremity; Male; Middle Aged; Prospective Studies; Risk Factors; Vascular Diseases | 2018 |
Watermelon and l-arginine consumption improve serum lipid profile and reduce inflammation and oxidative stress by altering gene expression in rats fed an atherogenic diet.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Citrulline; Citrullus; Diet, Atherogenic; Dietary Supplements; Gene Expression; Gene Expression Regulation; Hydroxymethylglutaryl CoA Reductases; Inflammation; Lipid Metabolism; Lipids; Liver; Male; NF-kappa B; Oxidative Stress; Plant Preparations; Rats, Sprague-Dawley; Sterol Regulatory Element Binding Protein 2 | 2018 |
ADMA and NT pro-BNP are associated with overall mortality in elderly.
Topics: Age Distribution; Aged; Aged, 80 and over; Arginine; Austria; Biomarkers; Body Mass Index; Cardiovascular Diseases; Female; Health Services for the Aged; Hospitalization; Humans; Male; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Risk Factors; Sex Distribution; Survival Analysis | 2019 |
Methylglyoxal as a prognostic factor in patients with chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Deoxyglucose; Diabetic Nephropathies; Disease Progression; Female; Humans; Japan; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyruvaldehyde; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Up-Regulation | 2019 |
Impact of arsenic exposure on clinical biomarkers indicative of cardiovascular disease risk in Mexican women.
Topics: Adult; Aged; Arginine; Arsenic; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Drinking Water; Environmental Exposure; Fatty Acid-Binding Proteins; Female; Humans; Male; Mexico; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Risk Factors; Surveys and Questionnaires; Water Pollutants, Chemical | 2019 |
Protein-energy wasting and asymmetric dimethylarginine in peritoneal dialysis patients.
Topics: Adiponectin; Adult; Aged; Arginine; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Energy Metabolism; Humans; Interleukin-6; Kidney Failure, Chronic; Leptin; Lipoproteins, LDL; Middle Aged; Peritoneal Dialysis; Risk Factors; Tumor Necrosis Factor-alpha | 2018 |
Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and cardiovascular disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensins; Animals; Arginine; Cardiovascular Diseases; Deoxyguanosine; Disease Models, Animal; Humans; Hypertension; Hypoxia; Kidney; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Oxidative Stress; Sympathectomy; Sympathetic Nervous System | 2018 |
The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine.
Topics: Arginine; Cardiovascular Diseases; HEK293 Cells; Homoarginine; Humans; Inhibitory Concentration 50; Kidney; Kinetics; Organic Anion Transporters; Toxins, Biological | 2019 |
Plasma ADMA, urinary ADMA excretion, and late mortality in renal transplant recipients.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Creatinine; Female; Gas Chromatography-Mass Spectrometry; Humans; Kidney Transplantation; Male; Middle Aged; Netherlands; Tandem Mass Spectrometry; Transplant Recipients | 2019 |
Establishment of reference values for the lysine acetylation marker N
Topics: Adolescent; Adult; Arginine; Biomarkers; Cardiovascular Diseases; Carnitine; Chromatography, Liquid; Citrulline; Creatinine; Female; Homoarginine; Humans; Lysine; Male; Middle Aged; Ornithine; Reference Values; Renal Insufficiency, Chronic; Tandem Mass Spectrometry; Young Adult | 2019 |
Heat-assisted extraction for the determination of methylarginines in serum by CE.
Topics: Arginine; Cardiovascular Diseases; Electrophoresis, Capillary; Hot Temperature; Humans; omega-N-Methylarginine; Solid Phase Extraction | 2013 |
A comparison of the association between glomerular filtration and L-arginine status in HIV-infected and uninfected African men: the SAfrEIC study.
Topics: Adult; Aged; Anti-Retroviral Agents; Arginine; Biomarkers; Black People; Cardiovascular Diseases; Glomerular Filtration Rate; HIV Infections; Humans; Hypertension; Kidney; Male; Middle Aged; Nitric Oxide; Regression Analysis; Risk Factors; South Africa | 2013 |
Association of lipid peroxidation with endothelial dysfunction in patients with overt hypothyroidism.
Topics: Adult; Antioxidants; Arginine; Cardiovascular Diseases; Case-Control Studies; Endothelium, Vascular; Female; Humans; Hypothyroidism; Lipid Peroxidation; Male; Malondialdehyde; Nitric Oxide; Risk Factors | 2013 |
Editorial (hot topic: cardiovascular disease biomarkers: from tradition to modernity).
Topics: Adiponectin; Arginine; Biomarkers; Cardiovascular Diseases; Cystatin C; Endothelins; Glycopeptides; Humans; MicroRNAs; Natriuretic Peptide, Brain; Peptide Fragments; Peroxidase; Predictive Value of Tests; Troponin | 2013 |
Asymmetric dimethylarginine predicts survival in the elderly.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Cardiovascular Diseases; Cause of Death; Chromatography, Liquid; Female; Follow-Up Studies; Humans; Italy; Male; Population Surveillance; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Tandem Mass Spectrometry; Time Factors | 2013 |
Endothelial dysfunction, inflammation and malnutrition markers as predictors of mortality in dialysis patients: multimarker approach.
Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Inflammation; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Malnutrition; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Risk Assessment; ROC Curve; Serum Albumin; Serum Amyloid A Protein | 2013 |
Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.
Topics: Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Endothelium; Female; Gene Expression; Humans; Kidney; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; RNA, Messenger; Serum Amyloid P-Component; Subcutaneous Fat, Abdominal; Uremia; Vascular Resistance | 2013 |
Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.
Topics: Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Lysine; Male; Middle Aged | 2013 |
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Esomeprazole; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Proton Pump Inhibitors; Risk Factors; Vasodilation | 2013 |
Effects of non-surgical periodontal treatment on the L-arginine-nitric oxide pathway and oxidative status in platelets.
Topics: Adult; Arginine; Blood Platelets; C-Reactive Protein; Cardiovascular Diseases; Cyclic GMP; Humans; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Periodontitis; Platelet Activation; Platelet Aggregation; Signal Transduction | 2013 |
Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Cardiovascular Diseases; Coronary Angiography; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Referral and Consultation; Risk Assessment; Risk Factors; Stroke; Survival Rate; Time Factors | 2013 |
Effects of acute and chronic stress on the L-arginine nitric oxide pathway in black and white South Africans: the sympathetic activity and ambulatory blood pressure in Africans study.
Topics: Acute Disease; Adult; Arginine; Black People; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Chronic Disease; Cold Temperature; Cross-Sectional Studies; Disease Susceptibility; Female; Hemodynamics; Humans; Male; Middle Aged; Motor Activity; Nitric Oxide; Pressure; Rest; South Africa; Stress, Psychological; Stroop Test; White People | 2013 |
Changes in biomarkers associated with living kidney donation.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Cohort Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Kidney Transplantation; Living Donors; Male; Middle Aged; Risk Factors; Tissue and Organ Harvesting | 2013 |
Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Factors; Texas | 2013 |
Leptin receptor Arg109 homozygotes display decreased total mortality as well as lower incidence of cardiovascular disease and related death.
Topics: Adult; Arginine; Cardiovascular Diseases; Coronary Disease; Female; Genotype; Homozygote; Humans; Incidence; Male; Middle Aged; Receptors, Leptin; Risk Factors | 2014 |
The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression.
Topics: Adenosine Deaminase; Adult; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cross-Sectional Studies; Female; HIV Infections; HIV Seropositivity; Humans; Immunoglobulin G; Interleukin-6; Male; Viral Load | 2014 |
Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes.
Topics: Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Environment; Female; Genotype; Humans; Intermittent Claudication; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors | 2014 |
Lipoprotein apheresis reduces biomarkers of plaque destabilization and cardiovascular risk.
Topics: Adult; Aged; Arginine; Biomarkers; Blood Component Removal; C-Reactive Protein; Cardiovascular Diseases; Female; Humans; Lipoproteins; Male; Matrix Metalloproteinase 9; Middle Aged; Plaque, Atherosclerotic; Pregnancy-Associated Plasma Protein-A; Vascular Cell Adhesion Molecule-1 | 2014 |
Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease.
Topics: Animals; Arginine; Cardiovascular Diseases; Humans; Inflammation; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Reactive Oxygen Species; Risk Factors | 2013 |
Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis.
Topics: Aged; Arginine; Arthritis, Rheumatoid; Cardiovascular Diseases; Endocardium; Female; Humans; Male; Middle Aged; Risk Assessment | 2014 |
Asymmetric dimethyl L-arginine, nitric oxide and cardiovascular disease in adolescent type 1 diabetics.
Topics: Adolescent; Arginine; Brachial Artery; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Egypt; Electrocardiography; Female; Humans; Lipids; Male; Nitric Oxide; Ultrasonography | 2014 |
Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection.
Topics: Adult; Analysis of Variance; Antiviral Agents; Arginine; Cardiovascular Diseases; Chromatography, Liquid; Depression; Depressive Disorder; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Nitric Oxide Synthase; Prospective Studies; Psychiatric Status Rating Scales; Regression Analysis; Ribavirin; Risk Factors; Time Factors | 2014 |
Letter by Chyrchel et al regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".
Topics: Animals; Arginine; Cardiovascular Diseases; Gastroesophageal Reflux; Humans; Male; Proton Pump Inhibitors | 2014 |
Letter by Montenegro and Lundberg regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".
Topics: Animals; Arginine; Cardiovascular Diseases; Gastroesophageal Reflux; Humans; Male; Proton Pump Inhibitors | 2014 |
Letter by Pinheiro et al regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".
Topics: Animals; Arginine; Cardiovascular Diseases; Gastroesophageal Reflux; Humans; Male; Proton Pump Inhibitors | 2014 |
Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".
Topics: Animals; Arginine; Cardiovascular Diseases; Gastroesophageal Reflux; Humans; Male; Proton Pump Inhibitors | 2014 |
Arginase activity and nitric oxide levels in patients with obstructive sleep apnea syndrome.
Topics: Adult; Analysis of Variance; Arginase; Arginine; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Polysomnography; Sleep Apnea, Obstructive | 2014 |
The effects of Ramadan fasting on endothelial function in patients with cardiovascular diseases.
Topics: Adult; Arginine; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Endothelium, Vascular; Fasting; Humans; Islam; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Peripheral Arterial Disease; Vascular Endothelial Growth Factor A | 2014 |
Effect of long-term GH replacement therapy on cardiovascular outcomes in isolated GH deficiency compared with multiple pituitary hormone deficiencies: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
Topics: Adult; Arginine; Body Mass Index; Cardiovascular Diseases; Cholesterol; Female; Follow-Up Studies; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hypopituitarism; Insulin; Insulin-Like Growth Factor I; Male; Middle Aged; Risk Factors; Triglycerides; Waist Circumference | 2014 |
Incidence of all-cause and cardiovascular mortality predicted by symmetric dimethylarginine in the population-based study of health in pomerania.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Cardiovascular Diseases; Female; Humans; Incidence; Male; Middle Aged; Young Adult | 2014 |
GC-MS and GC-MS/MS measurement of the cardiovascular risk factor homoarginine in biological samples.
Topics: Arginine; Cardiovascular Diseases; Female; Gas Chromatography-Mass Spectrometry; Homoarginine; Humans; Male; Risk Factors; Sputum | 2014 |
Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania.
Topics: Adult; Aged; Arginine; Biomarkers; Body Mass Index; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Female; Homoarginine; Humans; Male; Middle Aged; Reference Values; Renal Insufficiency, Chronic; Risk Factors; Tandem Mass Spectrometry | 2014 |
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin.
Topics: Aged; Arginine; Aspirin; Biomarkers; Cardiovascular Diseases; Case-Control Studies; CD40 Ligand; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Thromboxane B2; Wnt Signaling Pathway | 2014 |
Investigating the cardio-protective abilities of supplemental L-arginine on parameters of endothelial function in a hypercholesterolemic animal model.
Topics: Amidohydrolases; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Cardiotonic Agents; Cardiovascular Diseases; Dietary Supplements; Disease Models, Animal; Enalapril; Endothelium, Vascular; Heart; Hypercholesterolemia; Male; Malondialdehyde; Nitric Oxide; Nitroglycerin; Oxidative Stress; Rabbits | 2014 |
Aging of the nitric oxide system: are we as old as our NO?
Topics: Aged; Aging; Arginine; Blood Platelets; Cardiovascular Diseases; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitric Oxide; Platelet Aggregation; Prospective Studies | 2014 |
Asymmetric dimethylarginine and Ramadan fasting.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Fasting; Humans; Male; Malondialdehyde; Nitric Oxide; Vascular Endothelial Growth Factor A | 2014 |
Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study.
Topics: Aged; Arginine; Arthritis, Rheumatoid; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Regression Analysis; Risk Factors; Severity of Illness Index | 2015 |
Cardiovascular-renal changes after kidney donation: one-year follow-up study.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Interleukin-6; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Nephrectomy; Prospective Studies; Risk Factors; Time Factors; Tissue Donors; Treatment Outcome; Uric Acid; Vascular Cell Adhesion Molecule-1; Vasodilation; Young Adult | 2015 |
Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Arginine; Bacterial Translocation; Biomarkers; Cardiovascular Diseases; Female; Fibrin Fibrinogen Degradation Products; HIV Infections; Humans; Lipopolysaccharide Receptors; Lipopolysaccharides; Male; Middle Aged; Monocytes | 2014 |
Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Cardiovascular Diseases; Echocardiography, Doppler; Female; Heart Failure, Diastolic; Homoarginine; Humans; Logistic Models; Male; Middle Aged; Nitric Oxide; Reference Values; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Stroke Volume | 2014 |
Interhelical interaction and receptor phosphorylation regulate the activation kinetics of different human β1-adrenoceptor variants.
Topics: Arginine; Arrestins; beta-Arrestins; Cardiovascular Diseases; Crystallography, X-Ray; Cyclic AMP; Fluorescence Resonance Energy Transfer; HEK293 Cells; Humans; Microscopy, Confocal; Mutagenesis, Site-Directed; Phosphorylation; Polymorphism, Single Nucleotide; Protein Binding; Protein Conformation; Receptors, Adrenergic, beta-1; Receptors, G-Protein-Coupled; RNA, Small Interfering; Signal Transduction | 2015 |
Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Middle Aged; Prognosis; Prospective Studies; Risk Assessment; Risk Factors | 2014 |
Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs.
Topics: Adult; Animals; Anti-Inflammatory Agents; Arginine; Biomarkers; Cardiovascular Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Culture Techniques; Young Adult | 2015 |
Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity.
Topics: Adult; Arginine; Arthritis, Psoriatic; Asymptomatic Diseases; Atherosclerosis; Brachial Artery; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Cross-Sectional Studies; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Severity of Illness Index; Vasodilation | 2015 |
Interleukin-6 and asymmetric dimethylarginine are associated with platelet activation after percutaneous angioplasty with stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Blood Platelets; C-Reactive Protein; Cardiovascular Diseases; Creatinine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Integrin beta3; Interleukin-6; Male; Middle Aged; Monocytes; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Risk Factors; Smoking; Stents | 2015 |
Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Female; Follow-Up Studies; Homoarginine; Humans; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors | 2015 |
The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
Topics: Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Female; Glomerular Filtration Rate; Humans; Longitudinal Studies; Male; Middle Aged; Parathyroid Hormone; Renal Insufficiency, Chronic; Retrospective Studies; Serum Albumin; Triglycerides | 2015 |
Asymmetric dimethylarginine is negatively correlated with hyperglycemia in children.
Topics: Adolescent; Arginine; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Cardiomyopathies; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hyperglycemia; Japan; Male; Pediatric Obesity; Risk | 2015 |
Asymmetric dimethylarginine reflects cumulative inflammatory burden in rheumatoid arthritis. A novel mechanism of excessive cardiovascular morbidity?
Topics: Arginine; Arthritis, Rheumatoid; Cardiovascular Diseases; Disease Progression; Female; Humans; Inflammation; Male; Severity of Illness Index | 2015 |
The relationship between serum asymmetric dimethylarginine levels and subjective sleep quality in normotensive patients with type 2 diabetes mellitus.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Risk Factors; Sleep; Sleep Wake Disorders; Surveys and Questionnaires | 2015 |
Novel oral anticoagulants and reversal agents: Considerations for clinical development.
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Cardiovascular Diseases; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Piperazines; Recombinant Proteins; Stroke | 2015 |
Heat Shock Proteins, L-Arginine, and Asymmetric Dimethylarginine Levels in Patients With Obstructive Sleep Apnea Syndrome.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus; Disease Susceptibility; Endothelium, Vascular; Female; Heat-Shock Proteins; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Obesity; Oxidative Stress; Polysomnography; Risk Factors; Sleep Apnea, Obstructive; Smoking; Turkey | 2015 |
Letter by Kruszelnicka et al regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs".
Topics: Animals; Anti-Inflammatory Agents; Arginine; Cardiovascular Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Humans; Male | 2015 |
Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs".
Topics: Animals; Anti-Inflammatory Agents; Arginine; Cardiovascular Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Humans; Male | 2015 |
Symmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6-Year Follow-Up Study.
Topics: Aged; Area Under Curve; Arginine; Arthritis, Rheumatoid; Atherosclerosis; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Risk Factors | 2015 |
ADMA and arginine derivatives in relation to non-invasive vascular function in the general population.
Topics: Adult; Aged; Arginine; Blood Flow Velocity; Brachial Artery; Cardiovascular Diseases; Cross-Sectional Studies; Enzyme Inhibitors; Female; Germany; Humans; Male; Middle Aged; Nitric Oxide Synthase; Population Surveillance; Prevalence; Retrospective Studies; Vasodilation | 2016 |
Soluble receptor and gene polymorphism for AGE: relationship with obesity and cardiovascular risks.
Topics: Adolescent; Alleles; Arginine; Atherosclerosis; Biomarkers; Blood Pressure; Cardiovascular Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Lipids; Male; Pediatric Obesity; Polymorphism, Genetic; Receptor for Advanced Glycation End Products; Regression Analysis; Risk Factors | 2016 |
Relationship between FEV
Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Forced Expiratory Volume; Humans; Inflammation; Interleukin-6; Italy; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Risk Factors; Statistics as Topic; Vascular Stiffness | 2017 |
Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
Topics: Academic Medical Centers; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cause of Death; Cohort Studies; Female; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Severity of Illness Index; Survival Analysis; Uric Acid | 2016 |
Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus.
Topics: Adolescent; alpha-2-HS-Glycoprotein; Arginine; Biomarkers; Cardiovascular Diseases; Child; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Cardiomyopathies; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Greece; Humans; Male; Osteoprotegerin; RANK Ligand; Reproducibility of Results | 2017 |
Elevated plasma ADMA contributes to development of endothelial dysfunction in children with acute lymphoblastic leukemia.
Topics: Adolescent; Arginine; Cardiovascular Diseases; Child; Child, Preschool; Endothelial Cells; Endothelium-Dependent Relaxing Factors; Enzyme Inhibitors; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 2016 |
Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
Topics: Adolescent; Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oxidative Stress; Prognosis; Prospective Studies; Risk Factors; Young Adult | 2017 |
[Effect of asymmetrical dimethylarginine for predicting pro-thrombotic risk in atrial fibrillation].
Topics: Arginine; Atrial Fibrillation; Cardiovascular Diseases; Heart Atria; Humans; Stereoisomerism; Thrombosis | 2016 |
Skin Autofluorescence and Pentosidine Are Associated With Aortic Stiffening: The Maastricht Study.
Topics: Adult; Aged; Analysis of Variance; Arginine; Blood Pressure; Cardiovascular Diseases; Chi-Square Distribution; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glucose; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Linear Models; Lysine; Middle Aged; Optical Imaging; Prospective Studies; Pulse Wave Analysis; Skin; Vascular Stiffness | 2016 |
Diabetes-linked transcription factor HNF4α regulates metabolism of endogenous methylarginines and β-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2.
Topics: Aminoisobutyric Acids; Animals; Arginine; Cardiovascular Diseases; Cell Line; Diabetes Mellitus, Type 2; Gene Expression Regulation; Hepatocyte Nuclear Factor 4; Humans; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk; RNA, Small Interfering; Transaminases | 2016 |
The role of laser Doppler flowmetry tests, serum angiopoietin-2, asymmetric and symmetric dimethylarginine to predict outcome in chronic kidney disease.
Topics: Age Factors; Aged; Angiopoietin-2; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Hyperemia; Laser-Doppler Flowmetry; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Renal Circulation; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors | 2017 |
Carotid Plaque Score and Risk of Cardiovascular Mortality in the Oldest Old: Results from the TOOTH Study.
Topics: Aged; Aged, 80 and over; Aging; Arginine; Cardiovascular Diseases; Carotid Stenosis; Cohort Studies; Female; Humans; Japan; Kaplan-Meier Estimate; Male; Multivariate Analysis; Proportional Hazards Models; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2018 |
Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Homocysteine; Humans; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peroxidase; Renal Dialysis; Risk Factors | 2008 |
Asymmetric dimethylarginine (ADMA) has a role in regulating systemic vascular tone in young healthy subjects: the cardiovascular risk in young Finns study.
Topics: Adult; Arginine; Blood Pressure; Cardiovascular Diseases; Female; Finland; Humans; Kidney; Lipids; Male; Nitric Oxide; Risk Factors; Vascular Resistance; Vasoconstriction; Young Adult | 2008 |
[Asymmetric dimethil-arginine (ADMA) as a link between insulin resistance and atherosclerosis].
Topics: Adult; Arginine; Atherosclerosis; Cardiovascular Diseases; Carotid Stenosis; Chromatography; Enzyme Inhibitors; Female; Homocysteine; Humans; Insulin Resistance; Linear Models; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography, Doppler, Color | 2008 |
Obstructive sleep apnoea syndrome is associated with enhanced sub-clinical inflammation and asymmetric dimethyl-arginine levels in hypertensives.
Topics: Adult; Arginine; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Humans; Hypertension; Inflammation; Interleukin-18; Interleukin-6; Male; Middle Aged; Risk Factors; Severity of Illness Index; Sleep Apnea, Obstructive; Tumor Necrosis Factor-alpha | 2009 |
Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients.
Topics: Arginine; Cardiovascular Diseases; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neopterin; Renal Dialysis; Risk Factors | 2008 |
Increased plasma levels of asymmetric dimethylarginine and soluble CD40 ligand in patients with sleep apnea.
Topics: Adult; Arginine; Atherosclerosis; Cardiovascular Diseases; Case-Control Studies; CD40 Ligand; Endothelin-1; Humans; Male; Middle Aged; Risk Factors; Sleep Apnea, Obstructive | 2009 |
Smoker's paradox in heart failure: might asymmetric dimethylarginine be the possible explanation?
Topics: Arginine; Cardiovascular Diseases; Heart Failure; Hospital Mortality; Humans; Smoking | 2008 |
Relation of Trp64Arg polymorphism of beta3-adrenoreceptor gene with cardiovascular risk factors in presurgical morbidly obese patients.
Topics: Adipokines; Adult; Aged; Animals; Arginine; Body Weight; Calorimetry, Indirect; Cardiovascular Diseases; Diet; Female; General Surgery; Humans; Male; Middle Aged; Obesity; Polymorphism, Genetic; Receptors, Adrenergic, beta-3; Risk Factors; Tryptophan | 2008 |
Plasma levels of asymmetric dimethylarginine in premature neonates: its possible involvement in developmental programming of chronic diseases.
Topics: Arginine; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Male; Metabolic Syndrome | 2009 |
hsCRP, sICAM-1 and TAFI in hemodialysis patients: linking inflammation and hypofibrinolysis to cardiovascular events.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Fibrinolysis; Humans; Inflammation; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic | 2008 |
Variation in L-arginine intake follow demographics and lifestyle factors that may impact cardiovascular disease risk.
Topics: Adolescent; Adult; Aged; Arginine; Body Mass Index; Cardiovascular Diseases; Demography; Diabetes Mellitus; Female; Health Surveys; Humans; Life Style; Male; Middle Aged; Nutrition Surveys; Obesity; Prevalence; Risk Factors; Sex Distribution; Smoking; United States; Young Adult | 2008 |
The beneficial effects of angiotensin-converting enzyme inhibitors on serum asymmetric dimethylarginine levels in the patients with cardiovascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Cardiovascular Diseases; Humans | 2010 |
Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Mass Spectrometry; Middle Aged; Nitric Oxide; Proportional Hazards Models; Prospective Studies; Risk | 2009 |
Clinical implications of elevated asymmetric dimethylarginine in chronic kidney disease and end-stage renal disease.
Topics: Arginine; Cardiovascular Diseases; Carotid Arteries; Humans; Kidney Diseases; Kidney Failure, Chronic; Risk Factors; Uremia | 2009 |
[Novel risk factors for cardiovascular disease and tobacco smoke].
Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Causality; Comorbidity; Environmental Monitoring; Epidemiological Monitoring; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Smoking; Tobacco Smoke Pollution | 2008 |
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.
Topics: Aged; Arginine; Cardiovascular Diseases; Cause of Death; Diabetes Mellitus; Follow-Up Studies; Humans; Incidence; Middle Aged; Mortality; Predictive Value of Tests; Prognosis; Proportional Hazards Models | 2009 |
HDL-cholesterol, blood pressure, and asymmetric dimethylarginine are significantly associated with arterial wall thickness in children.
Topics: Arginine; Biomarkers; Blood Pressure; Cardiovascular Diseases; Carotid Arteries; Carotid Artery Diseases; Child; Cholesterol, HDL; Cross-Sectional Studies; Disease Progression; Female; Humans; Male; New South Wales; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography | 2009 |
Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort.
Topics: Age Factors; Aged; Arginine; Cardiovascular Diseases; Chromatography, Liquid; Cohort Studies; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Reference Standards; Sensitivity and Specificity; Sex Factors; Tandem Mass Spectrometry | 2009 |
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Citrulline; Coronary Artery Disease; Creatinine; Female; Humans; Lysine; Male; Metabolomics; Methylation; Middle Aged; Nitric Oxide Synthase; Odds Ratio; omega-N-Methylarginine; Ornithine; Prognosis; Prospective Studies; Protein Processing, Post-Translational; Risk Assessment; Risk Factors; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Time Factors | 2009 |
Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Risk Factors; Th1 Cells; Young Adult | 2009 |
Play it safe, avoid L-arginine supplements.
Topics: Arginine; Cardiovascular Diseases; Dietary Supplements; Humans; Myocardial Infarction; Nitric Oxide | 2006 |
Determinants of occurrence of aortic sclerosis in an aging population.
Topics: Age Factors; Aged; Aorta; Aortic Valve; Aortic Valve Stenosis; Arginine; Biomarkers; Blood Platelets; Body Mass Index; Calcinosis; Cardiovascular Diseases; Cross-Sectional Studies; Disease Progression; Echocardiography, Doppler; Elasticity; Endothelium, Vascular; Female; Heart Valve Diseases; Humans; Linear Models; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Platelet Aggregation; Prospective Studies; Pulsatile Flow; Risk Assessment; Risk Factors; Sclerosis | 2009 |
Ask the doctor. My husband is taking arginine and citrulline supplements because he read that they will protect his heart and arteries. Should I try these supplements, too, or is this a waste of money?
Topics: Amino Acids; Arginine; Cardiovascular Diseases; Cardiovascular System; Citrulline; Coronary Vessels; Humans; Nitric Oxide | 2009 |
Asymmetric dimethylarginine, NO and collateral growth.
Topics: Arginine; Atherosclerosis; Cardiovascular Diseases; Collateral Circulation; Coronary Artery Disease; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Risk Factors | 2009 |
DDAH2 mRNA expression is inversely associated with some cardiovascular risk-related features in healthy young adults.
Topics: Adult; Amidohydrolases; Anthropometry; Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Interleukin-6; Life Style; Male; Nitric Oxide Synthase Type III; Protein-Arginine N-Methyltransferases; Repressor Proteins; Risk Factors; RNA, Messenger; Tumor Necrosis Factor-alpha; Young Adult | 2009 |
Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients.
Topics: Adult; Arginine; Cardiovascular Diseases; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Middle Aged; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome | 2010 |
Asymmetric dimethylarginine: understanding the physiology, genetics, and clinical relevance of this novel biomarker. Proceedings of the 4th International Symposium on ADMA.
Topics: Arginine; Austria; Biomarkers; Cardiovascular Diseases; Humans; Internationality; Nitric Oxide | 2009 |
Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicities.
Topics: Aged; Arginine; Asian People; Black People; Cardiovascular Diseases; Cystatin C; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Filtration Rate; Hispanic or Latino; Humans; Male; Middle Aged; Regression Analysis; Risk Factors; White People | 2010 |
Increased serum nitric oxide concentration after bariatric surgery--a potential mechanism for cardiovascular benefit.
Topics: Adult; Aged; Arginine; Bariatric Surgery; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Nitric Oxide; Obesity, Morbid; Risk Factors; Weight Loss; Young Adult | 2010 |
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Benzopyrans; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Endothelium, Vascular; Ethanolamines; Exercise Tolerance; Heart Failure; Heart Rate; Hemodynamics; Humans; Hypertension; Nebivolol; Nitric Oxide; Stroke Volume; Vascular Resistance; Vasodilation; Vasodilator Agents | 2010 |
Circulating angiopoietin-2 levels increase with progress of chronic kidney disease.
Topics: Adult; Aged; Angiopoietin-2; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Chronic Disease; Disease Progression; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Nephrectomy; Risk Factors; Tissue Donors | 2010 |
Polyamine intake, dietary pattern, and cardiovascular disease.
Topics: Animals; Arginine; Cardiovascular Diseases; Cytokines; Diet, Mediterranean; Gene Expression Regulation; Humans; Lymphocyte Function-Associated Antigen-1; Mice; Nitric Oxide; Polyamines | 2010 |
Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.
Topics: Amidohydrolases; Animals; Aorta; Apolipoproteins E; Arginine; Atherosclerosis; Blood Pressure; Cardiovascular Diseases; Humans; Male; Mice; Mice, Transgenic; Models, Genetic; Nitric Oxide; Risk | 2010 |
High fat diets modulate nitric oxide biosynthesis and antioxidant defence in red blood cells from C57BL/6 mice.
Topics: Animals; Antioxidants; Arginine; Cardiovascular Diseases; Dietary Fats; Dietary Fats, Unsaturated; Erythrocytes; Fatty Acids; Fatty Acids, Monounsaturated; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Olive Oil; Oxidative Stress; Plant Oils | 2010 |
Association between exaggerated blood pressure response to exercise and serum asymmetric dimethylarginine levels.
Topics: Adult; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Case-Control Studies; Chromatography, High Pressure Liquid; Exercise; Exercise Test; Female; Humans; Hypertension; Male; Middle Aged; Predictive Value of Tests | 2010 |
[Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors].
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Blood Proteins; Cardiovascular Diseases; Comorbidity; Cross-Sectional Studies; Diabetes Complications; Female; Humans; Hyperhomocysteinemia; Hyperlipidemias; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prevalence; Risk Factors; Smoking; Stroke Volume; Ultrasonography; Uremia | 2010 |
HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application.
Topics: Adolescent; Adult; Aged; Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Creatine; Endothelium, Vascular; Female; Glomerular Filtration Rate; Humans; Kidney Function Tests; Male; Middle Aged; Renal Insufficiency, Chronic; Young Adult | 2010 |
Methylation cycle, arginine-creatine pathway and asymmetric dimethylarginine in paediatric renal transplant.
Topics: Acute Kidney Injury; Adolescent; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Child; Creatine; Creatinine; Cystatin C; Female; Glomerular Filtration Rate; Humans; Kidney Function Tests; Kidney Transplantation; Male; Methylation; Prognosis; Risk Factors; Survival Rate | 2011 |
Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Risk Factors; Spondylitis, Ankylosing | 2011 |
Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.
Topics: Adiponectin; Adult; Aged; Aldehydes; Arginine; Biomarkers; Body Mass Index; Body Weight; C-Reactive Protein; Cardiovascular Diseases; Endothelium; Female; Humans; Inflammation; Interleukin-6; Leptin; Lipoproteins, LDL; Male; Malnutrition; Malondialdehyde; Middle Aged; Nutritional Status; Oxidative Stress; Peritoneal Dialysis; Risk Factors; Tumor Necrosis Factor-alpha | 2010 |
Levels of asymmetrical dimethylarginine are predictive of brachial artery flow-mediated dilation 6 years later. The Cardiovascular Risk in Young Finns Study.
Topics: Adult; Arginine; Brachial Artery; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cohort Studies; Endothelium, Vascular; Female; Finland; Humans; Male; Middle Aged; Multivariate Analysis; Risk Factors | 2010 |
The relationship between reduced testosterone, stimulated growth hormone secretion and increased carotid intima-media thickness in obese men.
Topics: Adult; Arginine; Cardiovascular Diseases; Carotid Arteries; Human Growth Hormone; Humans; Male; Middle Aged; Obesity; Risk; Testosterone; Tunica Intima; Tunica Media; Ultrasonography | 2010 |
Evaluation of asymmetric dimethylarginine, nitric oxide levels and associated independent variables in obese and lean patients with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Female; Hormones; Humans; Nitric Oxide; Obesity; Polycystic Ovary Syndrome; Risk Factors; Young Adult | 2011 |
Serum asymmetric dimethylarginine levels in normotensive obese individuals.
Topics: Adult; Arginine; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Male; Middle Aged; Obesity; Risk Factors | 2010 |
Insulin resistance in obesity and metabolic syndrome: is there a connection with platelet l-arginine transport?
Topics: Adolescent; Arginine; Biological Transport; Blood Platelets; Cardiovascular Diseases; Case-Control Studies; Cyclic GMP; Humans; Insulin Resistance; Metabolic Syndrome; Nitric Oxide; Obesity | 2010 |
Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus.
Topics: Aged; Arginine; Asian People; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Regression Analysis; Risk Factors | 2011 |
Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Enzyme Inhibitors; Epidemiologic Methods; Female; Germany; Humans; Male; Nitric Oxide Synthase; Peripheral Arterial Disease; Prognosis | 2011 |
Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA(1c).
Topics: Adolescent; Albuminuria; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Glycated Hemoglobin; Humans; Longitudinal Studies; Male; Risk Factors | 2011 |
The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.
Topics: Aged; Amidohydrolases; Analysis of Variance; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Case-Control Studies; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cohort Studies; Coronary Angiography; Diabetes Mellitus, Type 2; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Insulin; Insulin Resistance; Kaplan-Meier Estimate; Linear Models; Linkage Disequilibrium; Logistic Models; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Genetic; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Taiwan | 2011 |
NO problem: arterial and venous endothelial function and erectile dysfunction.
Topics: Arginine; Arteries; Biomarkers; Blood Flow Velocity; Cardiovascular Diseases; Endothelium, Vascular; Humans; Impotence, Vasculogenic; Male; Nitric Oxide; Penile Erection; Penis; Predictive Value of Tests; Regional Blood Flow; Risk Assessment; Risk Factors; Severity of Illness Index; Ultrasonography, Doppler, Color; Up-Regulation; Veins | 2011 |
Relationship of asymmetric dimethylarginine with penile Doppler ultrasound parameters in men with vasculogenic erectile dysfunction.
Topics: Adult; Aged; Analysis of Variance; Arginine; Arteries; Biomarkers; Blood Flow Velocity; Cardiovascular Diseases; Case-Control Studies; Greece; Humans; Impotence, Vasculogenic; Male; Middle Aged; Penile Erection; Penis; Predictive Value of Tests; Regional Blood Flow; Regression Analysis; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Ultrasonography, Doppler, Color; Up-Regulation; Veins | 2011 |
Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease.
Topics: Adult; Arginine; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Graves Disease; Heart Rate; Hospitals, University; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Natriuretic Peptide, Brain; Peptide Fragments; Risk Factors; Thyroid Hormones; Thyroxine; Triiodothyronine | 2011 |
Exercise-induced alterations of retinal vessel diameters and cardiovascular risk reduction in obesity.
Topics: Adult; Arginine; Athletes; Cardiovascular Diseases; Enzyme-Linked Immunosorbent Assay; Exercise; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Nitric Oxide; Obesity; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; Surveys and Questionnaires | 2011 |
Arginine/asymmetric dimethylarginine ratio and cardiovascular risk factors in patients with predialytic chronic kidney disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Cardiovascular Diseases; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Risk Factors; Young Adult | 2011 |
Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria.
Topics: Adolescent; Amidohydrolases; Arginine; Cardiovascular Diseases; Child; Child, Preschool; Dimethylamines; Homocystinuria; Humans; Metabolic Networks and Pathways; Nitric Oxide; Phenylketonurias; Risk Factors; Young Adult | 2012 |
Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
Topics: Amidohydrolases; Animals; Arginine; Blood Pressure; Cardiovascular Diseases; Cells, Cultured; Endothelial Cells; Enzyme Inhibitors; Female; Genotype; Hypertension; Infusion Pumps, Implantable; Male; Mice; Mice, 129 Strain; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Phenotype; Risk Factors; RNA Interference; Substrate Specificity; Time Factors; Transfection | 2011 |
Vascular function in the diagnostic categories of polycystic ovary syndrome.
Topics: Adult; Arginine; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Humans; Insulin Resistance; Overweight; Phenotype; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Vascular Resistance | 2011 |
Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography.
Topics: Aged; Arginine; Cardiovascular Diseases; Chromatography; Citrulline; Coronary Angiography; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Models, Biological; Nitric Oxide; Ornithine; Proportional Hazards Models; Vascular Cell Adhesion Molecule-1 | 2011 |
Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.
Topics: Adult; Aged; Analysis of Variance; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cohort Studies; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Italy; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Proportional Hazards Models; Renal Dialysis; Risk Assessment; Risk Factors; Time Factors | 2011 |
DDAH says NO to ADMA.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Endothelial Cells; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Risk Factors; Substrate Specificity | 2011 |
Age-related modification of antioxidant enzyme activities in relation to cardiovascular risk factors.
Topics: Aged; Aged, 80 and over; Aging; Apolipoproteins A; Arginine; Cardiovascular Diseases; Catalase; Enzyme-Linked Immunosorbent Assay; Female; Fetuins; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lipoproteins; Lipoproteins, LDL; Male; Oxidation-Reduction; Oxidative Stress; Risk Factors; Statistics as Topic; Superoxide Dismutase | 2012 |
Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Death; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Referral and Consultation; Risk Factors | 2011 |
Day-night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea.
Topics: Adult; Arginine; Blood Coagulation; Body Mass Index; Cardiovascular Diseases; CD40 Ligand; Circadian Rhythm; Endothelium, Vascular; Erythrocyte Count; Factor VII; Humans; Leukocyte Count; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Count; Sleep Apnea Syndromes; von Willebrand Factor; Waist Circumference | 2012 |
Asymmetric dimethylarginine (ADMA): is really a biomarker for cardiovascular prognosis?
Topics: Arginine; Cardiovascular Diseases; Coronary Angiography; Female; Humans; Male; Referral and Consultation | 2011 |
Endothelial dysfunction and high cardiovascular risk profile in severe alcoholics improve only partially following a medium-term alcohol withdrawal.
Topics: Adult; Age of Onset; Aged; Alcoholism; Arginine; Biomarkers; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Confidence Intervals; Endothelium, Vascular; Female; Heart Rate; Humans; Insulin Resistance; Lipids; Logistic Models; Male; Middle Aged; Odds Ratio; Oxidative Stress; Risk Assessment; Smoking; Vasodilation | 2012 |
Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Dose-Response Relationship, Drug; Female; HL-60 Cells; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Models, Animal; Neutrophils; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxidase; Signal Transduction; Superoxides | 2011 |
Association of endodontic infection with detection of an initial lesion to the cardiovascular system.
Topics: Adult; Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Coronary Circulation; Cross-Sectional Studies; Dental Pulp Diseases; Echocardiography, Doppler; Echocardiography, Doppler, Pulsed; Electrocardiography; Endothelium, Vascular; Humans; Interleukin-1; Interleukin-2; Interleukin-6; Male; Periapical Periodontitis; Physical Examination; Prospective Studies; Radiography, Bitewing; Radiography, Panoramic; Risk Factors; Stroke Volume; Tumor Necrosis Factor-alpha; Ventricular Function, Left; Young Adult | 2011 |
Ethnicity-specific differences in L-arginine status in South African men.
Topics: Adult; Aged; Arginine; Black People; Cardiovascular Diseases; Cross-Sectional Studies; Humans; Hypertension; Linear Models; Male; Middle Aged; Multivariate Analysis; Prevalence; Risk Factors; South Africa; White People | 2012 |
High plasma pentosidine level is accompanied with cardiovascular events in hemodialysis patients.
Topics: Aged; Arginine; C-Reactive Protein; Cardiovascular Diseases; Female; Glycation End Products, Advanced; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Prognosis; Renal Dialysis; Risk | 2012 |
Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence.
Topics: Animals; Apoptosis; Arginine; Autophagy; Azoles; Cardiovascular Diseases; Cathepsins; Cell Membrane Permeability; Cells, Cultured; Cellular Senescence; Collagen Type I; Down-Regulation; Endothelial Cells; Endothelium, Vascular; Hydrogen Peroxide; Isoindoles; Lysosomes; Mice; Mice, Knockout; Mice, Transgenic; Organoselenium Compounds; Recombinant Proteins; Risk Factors; Sirtuin 1; Stem Cells; Stress, Physiological | 2012 |
Free asymmetric dimethylarginine (ADMA) is low in children and adolescents with classical phenylketonuria (PKU).
Topics: Adolescent; Arginine; Atherosclerosis; Blood Glucose; Cardiovascular Diseases; Child; Cross-Sectional Studies; Female; Homocysteine; Humans; Lipid Metabolism; Male; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Phenylalanine; Phenylketonurias | 2012 |
Optimization of the separation of NDA-derivatized methylarginines by capillary and microchip electrophoresis.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Electrophoresis, Capillary; Electrophoresis, Microchip; Humans; Lasers; Naphthalenes; Prognosis | 2012 |
High tea and vegetable consumption is associated with low ADMA generation in older healthy subjects.
Topics: Aged; Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Coffee; Enzyme Inhibitors; Feeding Behavior; Female; Fruit; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Nitric Oxide Synthase; Reference Values; Risk Factors; Tea; Vegetables | 2012 |
Low plasma levels of L-arginine, impaired intraplatelet nitric oxide and platelet hyperaggregability: implications for cardiovascular disease in depressive patients.
Topics: Adult; Amino Acids; Arginine; Blood Platelets; Cardiovascular Diseases; Cyclic GMP; Depressive Disorder, Major; Female; Guanylate Cyclase; Humans; Male; Nitric Oxide; Nitric Oxide Synthase; Platelet Aggregation; Risk Factors | 2012 |
Asymmetric dimethylarginine: a novel cardiovascular risk factor in end-stage renal disease.
Topics: Arginine; Cardiovascular Diseases; Carotid Intima-Media Thickness; Demography; Female; Humans; Indonesia; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Renal Dialysis; Risk Factors | 2012 |
Cardioprotective effect of a biofermented nutraceutical on endothelial function in healthy middle-aged subjects.
Topics: Adult; Age Factors; Arginine; C-Reactive Protein; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Dietary Supplements; Endothelium, Vascular; Female; Fermentation; Humans; Male; Middle Aged; Models, Biological; Nitric Oxide; Placebos; Time Factors | 2012 |
The association between serum asymmetric dimethyl arginine levels and a history of gestational diabetes among healthy women.
Topics: Adult; Arginine; Asymptomatic Diseases; Biomarkers; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Diabetes Complications; Diabetes, Gestational; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Pregnancy; Risk Factors | 2012 |
Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1).
Topics: Arginine; Biological Transport; Biomarkers; Cardiovascular Diseases; Cationic Amino Acid Transporter 1; Gene Expression; HEK293 Cells; Humans; Kinesics; Metformin; Risk | 2012 |
Elevated asymmetric dimethylarginine in young adult survivors of childhood acute lymphoblastic leukemia: a preliminary report.
Topics: Adolescent; Adult; Arginine; Cardiovascular Diseases; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Survivors | 2012 |
Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; CD4 Lymphocyte Count; Cholesterol; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; HIV; HIV Infections; Humans; Limit of Detection; Male; Middle Aged; Neopterin; Prospective Studies; RNA, Viral; Treatment Outcome; Triglycerides | 2012 |
Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Intercellular Adhesion Molecule-1; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Vascular Cell Adhesion Molecule-1; Waist Circumference; Weight Loss | 2012 |
Defective nitric oxide-cyclic guanosine monophosphate signaling in patients with bipolar disorder: a potential role for platelet dysfunction.
Topics: Adult; Arginase; Arginine; Bipolar Disorder; Blood Platelets; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Comorbidity; Cyclic GMP; Female; Humans; Inflammation; Male; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Signal Transduction; Superoxide Dismutase | 2012 |
Exploring disease activity and cardiovascular events by raised serum asymmetric dimethyl arginine among systemic lupus erythematosus patients.
Topics: Adult; Arginine; Cardiovascular Diseases; Cholesterol; Complement C3; Cross-Sectional Studies; Egypt; Female; Humans; Logistic Models; Lupus Erythematosus, Systemic; Male; Surveys and Questionnaires | 2011 |
Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals.
Topics: Adult; Aged; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Carotid Arteries; Cholesterol, LDL; Cross-Sectional Studies; Endothelial Cells; Fasting; Female; Femoral Artery; Glucose Tolerance Test; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Prediabetic State; Predictive Value of Tests; Pulse Wave Analysis; Risk Assessment; Risk Factors; Stem Cells; Vascular Stiffness | 2012 |
The relationship of plasma ADMA levels with cardiac functions and metabolic parameters in peritoneal dialysis patients.
Topics: Adolescent; Aged; Arginine; Aspirin; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Echocardiography; Heart; Humans; Hypertension; Middle Aged; Peritoneal Dialysis; Risk Factors | 2013 |
Transsulfuration pathway thiols and methylated arginines: the Hunter Community Study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aging; Amidohydrolases; Arginine; Australia; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Community Medicine; Cysteine; Dipeptides; Female; Glutathione; Homocysteine; Humans; Male; Middle Aged; Taurine | 2013 |
Endothelial damage, asymmetric dimethylarginine and cardiovascular risk in end-stage renal disease.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Kidney Failure, Chronic; Models, Cardiovascular; Risk Factors | 2002 |
Homocysteine and ADMA--emerging risk factors for cardiovascular disease?
Topics: Arginine; Cardiovascular Diseases; Homocysteine; Humans; Predictive Value of Tests; Risk Factors | 2002 |
Are advanced glycation end products cardiovascular risk factors in patients with CRF?
Topics: Adult; Aged; Aged, 80 and over; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Female; Glycation End Products, Advanced; Humans; Hypertrophy, Left Ventricular; Imidazoles; Kidney Failure, Chronic; Kidney Transplantation; Lysine; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Risk Factors | 2003 |
Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
Topics: Aged; Aged, 80 and over; Aging; Arginine; Cardiovascular Diseases; Cohort Studies; Female; Glomerular Filtration Rate; Humans; Inflammation; Kidney Failure, Chronic; Lysine; Male; Mortality; Nutrition Disorders; Prognosis; Prospective Studies; Renal Dialysis; Survival Analysis | 2003 |
High-performance liquid chromatographic assay of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine in human plasma by derivatization with naphthalene-2,3-dicarboxaldehyde.
Topics: Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Naphthalenes; Reference Standards; Reproducibility of Results; Spectrometry, Fluorescence; Stereoisomerism | 2003 |
Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Homocysteine; Humans; Kidney Transplantation; Lysine; Middle Aged; Renal Dialysis; Renal Insufficiency; Risk Factors; Smoking | 2003 |
When the endothelium cannot say 'NO' anymore. ADMA, an endogenous inhibitor of NO synthase, promotes cardiovascular disease.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase | 2003 |
Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease.
Topics: Aged; Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mitochondrial Proton-Translocating ATPases; Oxidative Phosphorylation Coupling Factors; Radioimmunoassay; Risk Factors | 2003 |
Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Homeostasis; Humans; Hyperhomocysteinemia; Hyperlipidemias; Nitric Oxide Synthase; Vasodilation | 2003 |
Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis.
Topics: Amidohydrolases; Arginine; Cardiovascular Diseases; Cells, Cultured; Coronary Angiography; Coronary Artery Disease; Cyclic GMP; Cytomegalovirus Infections; Endothelium, Vascular; Female; Heart Transplantation; Humans; Male; Middle Aged; Nitric Oxide Synthase; Nitrites; Oxidative Stress; Risk Factors; Signal Transduction | 2004 |
Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
Topics: Adult; Arginine; Biomarkers; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Morbidity; Nitric Oxide Synthase | 2004 |
n-3 polyunsaturated fatty acids supplementation decreases asymmetric dimethyl arginine and arachidonate accumulation in aging spontaneously hypertensive rats.
Topics: Aging; Animals; Arachidonic Acid; Arginine; Cardiovascular Diseases; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Male; Rats; Rats, Inbred SHR; Risk Factors | 2005 |
Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Topics: Adolescent; Apolipoproteins B; Arginine; Blood Glucose; Body Height; Cardiovascular Diseases; Carotid Arteries; Child; Child, Preschool; Cholesterol, LDL; Echocardiography, Doppler; Exercise; Female; Fibrinogen; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Infant; Insulin; Leptin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Risk Factors; Triglycerides | 2004 |
Low dialysance of asymmetric dimethylarginine (ADMA)--in vivo and in vitro evidence of significant protein binding.
Topics: Arginine; Cardiovascular Diseases; Creatine; Female; Humans; In Vitro Techniques; Kidney Failure, Chronic; Male; Middle Aged; Protein Binding; Renal Dialysis; Urea | 2004 |
Association between dietary arginine and C-reactive protein.
Topics: Adult; Aged; Arginine; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Confidence Intervals; Dietary Fiber; Energy Intake; Exercise; Female; Humans; Logistic Models; Male; Mental Recall; Middle Aged; Nutrition Surveys; Odds Ratio; Oxidation-Reduction; Risk Factors; Smoking | 2005 |
High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes.
Topics: Aged; Analysis of Variance; Arginine; Arteries; Biomechanical Phenomena; Brachial Artery; Cardiovascular Diseases; Carotid Arteries; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Humans; Linear Models; Lysine; Male; Middle Aged; Pulse; Tunica Intima; Tunica Media; Ultrasonography | 2005 |
Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.
Topics: Adult; Aged; Arginine; Arteriosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis | 2005 |
The frequency of Trp64Arg polymorphism of the beta3-adrenergic receptor gene in healthy and obese Hungarian children and its association with cardiovascular risk factors.
Topics: Alleles; Arginine; Blood Glucose; Cardiovascular Diseases; Case-Control Studies; Child; DNA Fragmentation; Female; Genetic Predisposition to Disease; Glucose Tolerance Test; Humans; Hungary; Hypertension; Insulin; Male; Obesity; Polymerase Chain Reaction; Polymorphism, Genetic; Proteins; Receptors, Adrenergic, beta-3; Tryptophan | 2005 |
Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Arginine; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; E-Selectin; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Middle Aged; Nitric Oxide Synthase; Piperazines; Purines; Risk Factors; Sildenafil Citrate; Sulfones | 2006 |
The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Topics: Adolescent; Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Enzyme Inhibitors; Female; Homocysteine; Hormone Replacement Therapy; Humans; Hypothyroidism; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Nitric Oxide; Risk Factors; Thyrotropin; Thyroxine; Triiodothyronine | 2005 |
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
Topics: Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; Creatinine; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Risk Factors | 2005 |
Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Nitric Oxide Synthase; Regression Analysis; Risk Factors; Severity of Illness Index | 2005 |
The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease.
Topics: Adult; Aged; Amino Acid Substitution; Analysis of Variance; Arginine; Aspartic Acid; Cardiovascular Diseases; Female; Gene Frequency; Genotype; Glutamic Acid; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide Synthase; Polymorphism, Genetic; Regression Analysis; Survival Rate | 2005 |
Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects.
Topics: Adult; Aged; Aging; Arginine; Biomarkers; Cardiovascular Diseases; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Reference Values; Sensitivity and Specificity; Sex Characteristics | 2005 |
Effects of ADMA upon gene expression: an insight into the pathophysiological significance of raised plasma ADMA.
Topics: Arginine; Atherosclerosis; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein Receptors, Type I; Bone Morphogenetic Proteins; Cardiovascular Diseases; Cell Culture Techniques; Endothelial Cells; Gene Expression Profiling; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Oligonucleotide Array Sequence Analysis; Protein-Arginine N-Methyltransferases; Smad5 Protein; Transforming Growth Factor beta | 2005 |
ADMA, endothelial progenitor cells, and cardiovascular risk.
Topics: Arginine; Cardiovascular Diseases; Endothelial Cells; Humans; Risk Factors; Stem Cells | 2005 |
The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
Topics: Adult; Arginine; Brachial Artery; Cardiovascular Diseases; Chronic Disease; Copper; Endothelium, Vascular; Erythrocytes; Female; Glomerular Filtration Rate; Glutathione Peroxidase; Humans; Kidney Diseases; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Selenium; Severity of Illness Index; Superoxide Dismutase; Vasodilation; Zinc | 2006 |
The discovery of nitric oxide and its role in vascular biology.
Topics: Animals; Arginine; Blood Vessels; Cardiovascular Diseases; Endothelium, Vascular; Free Radicals; History, 20th Century; History, 21st Century; Humans; Mitochondria; Nitric Oxide | 2006 |
The DDAH-ADMA-NOS pathway.
Topics: Amidohydrolases; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Models, Biological; Nitric Oxide; Nitric Oxide Synthase; Risk Factors | 2005 |
Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Cyclic GMP; Exercise; Female; Humans; Male; Middle Aged; Peroxidase; Risk Factors | 2005 |
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.
Topics: Adult; Arginine; Atherosclerosis; Cardiovascular Diseases; Carotid Artery, Common; Case-Control Studies; Cholesterol, HDL; Female; Follow-Up Studies; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Male; Middle Aged; Prospective Studies; Risk; Tunica Intima | 2006 |
Evidence for associations between common polymorphisms of estrogen receptor beta gene with homocysteine and nitric oxide.
Topics: Aged; Arginine; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Folic Acid; Genetic Variation; Genotype; Homocysteine; Humans; Linkage Disequilibrium; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Polymorphism, Single Nucleotide; Postmenopause; Risk Factors; Vitamin B 12 | 2006 |
GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Arginine; Blood Glucose; Body Composition; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Male; Middle Aged; Regression Analysis; Risk Factors | 2006 |
Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease.
Topics: Aged; Arginine; Arteries; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cohort Studies; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Osmolar Concentration; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Severity of Illness Index | 2006 |
Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
Topics: Arginine; Atherosclerosis; Cardiovascular Diseases; Comorbidity; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide Synthase; Proportional Hazards Models; Regression Analysis; Renal Dialysis; Risk Factors | 2006 |
Flavanols, cocoa, and cardiology.
Topics: Arginine; Cacao; Cardiovascular Agents; Cardiovascular Diseases; Cerebral Cortex; Endothelium, Vascular; Flavonoids; Humans; Nitric Oxide; Platelet Adhesiveness; Regional Blood Flow | 2006 |
Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).
Topics: Analysis of Variance; Arginine; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Humans; Male; Middle Aged; Mortality; Predictive Value of Tests; Regression Analysis; Risk Factors | 2007 |
Should we measure asymmetric dimethylarginine in patients with coronary artery disease?
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Coronary Artery Disease; Humans; Mortality; Predictive Value of Tests; Risk Factors | 2007 |
ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk.
Topics: Adult; Aged; Analysis of Variance; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Female; Humans; Insulin; Male; Middle Aged; Risk Factors; Vasodilation | 2007 |
A new perspective for the treatment of renal diseases?
Topics: Amidohydrolases; Arginine; Cardiovascular Diseases; Chronic Disease; Humans; Kidney Diseases; Nitric Oxide Synthase; Risk Factors | 2007 |
Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes.
Topics: Aged; Arginine; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Middle Aged; Predictive Value of Tests; Prospective Studies; Risk Assessment | 2007 |
Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nitric Oxide Synthase; Perioperative Care; Postoperative Complications; Prospective Studies; Risk Assessment; Surgical Procedures, Operative | 2007 |
Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study.
Topics: Adult; Arginine; Biomarkers; Brachial Artery; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Finland; Follow-Up Studies; Hemorheology; Humans; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Risk; Sampling Studies; Vasodilation | 2007 |
[Is the serum concentration of pentosidine a predictor of cardiovascular events in patients with type 2 diabetes and kidney disease?].
Topics: Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Lipoproteins, LDL; Lysine; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors | 2007 |
Unchanged asymmetric dimethylarginine levels in non-diabetic, premenopausal obese women who have common risk factors for cardiovascular disease.
Topics: Adult; Arginine; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Female; Humans; Insulin Resistance; Middle Aged; Obesity; Overweight; Premenopause; Regression Analysis; Risk Factors | 2007 |
Oxidative stress in cardiovascular disease: successful translation from bench to bedside?
Topics: Arginine; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Endothelium, Vascular; Hemorheology; Humans; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Risk; Thrombosis; Vasodilation | 2007 |
Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS).
Topics: Arginine; Body Mass Index; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Polysomnography; Severity of Illness Index; Sleep Apnea, Obstructive | 2008 |
Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
Topics: Adult; Aged; Arginine; Blood Flow Velocity; Cardiovascular Diseases; Case-Control Studies; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Circulation; Exercise Test; Female; Humans; Male; Middle Aged; Myocardium; Nitric Oxide; Sensitivity and Specificity; Thrombolytic Therapy | 2007 |
Intercellular adhesion molecule 1 (ICAM1) Lys56Met and Gly241Arg gene variants, plasma-soluble ICAM1 concentrations, and risk of incident cardiovascular events in 23,014 initially healthy white women.
Topics: Aged; Arginine; Cardiovascular Diseases; Female; Genetic Variation; Genotype; Glycine; Humans; Intercellular Adhesion Molecule-1; Lysine; Methionine; Middle Aged; Prospective Studies; Risk Factors; White People | 2007 |
Dimethylarginine dimethylaminohydrolase (DDAH)--a critical regulator of hypertensive left ventricular hypertrophy?
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Endothelium; Humans; Hypertension; Hypertrophy, Left Ventricular; Mice; Models, Biological; Nitric Oxide; Nitric Oxide Synthase; Risk; Risk Factors | 2008 |
Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
Topics: Acetylcholine; Amidohydrolases; Animals; Aorta; Arginine; Arterioles; Cardiovascular Diseases; Carotid Arteries; Cerebrovascular Circulation; Endothelium, Vascular; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Vasodilator Agents | 2008 |
Asymmetric dimethylarginine and impaired cardiovascular healing.
Topics: Apoptosis; Arginine; Cardiovascular Diseases; Humans; Kidney Diseases; Myocardial Ischemia; Nitric Oxide; Prognosis; Regeneration; Stem Cells; Treatment Outcome | 2009 |
Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
Topics: Adult; Albuminuria; Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2008 |
Obesity reduces the bioavailability of nitric oxide in juveniles.
Topics: Adolescent; Arginine; Cardiovascular Diseases; Citrulline; Female; Humans; Insulin Resistance; Male; Nitric Oxide; Obesity | 2008 |
Effects of moderate hyperhomocysteinaemia induced by 4 weeks methionine-enriched diet on metabolite profile and mesenteric artery function in rats.
Topics: Animals; Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Diet; Homocysteine; Hyperhomocysteinemia; Male; Mesenteric Arteries; Methionine; Rats; Rats, Wistar; Vasodilation | 2008 |
The arginine-creatine pathway is disturbed in children and adolescents with renal transplants.
Topics: Adolescent; Arginine; Cardiovascular Diseases; Case-Control Studies; Child; Creatine; Creatinine; Female; Glycine; Homocysteine; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Methylation; Risk Factors | 2008 |
Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.
Topics: Adult; Arginine; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin Resistance; Intercellular Adhesion Molecule-1; Obesity; Overweight; Receptors, Tumor Necrosis Factor, Type II | 2008 |
The homocysteine paradox.
Topics: Animals; Arginine; Cardiovascular Diseases; Cystatin C; Cystatins; Disease Models, Animal; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Risk Factors; Vitamin B 12; Vitamin B 6 | 2008 |
Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation.
Topics: Adult; Aged; Antithrombin III; Arginine; Cardiovascular Diseases; Disseminated Intravascular Coagulation; Female; Gabexate; Guanidines; Humans; Male; Middle Aged; Pipecolic Acids; Postoperative Care; Sulfonamides | 1984 |
The effect of malnutrition on cardiovascular mortality in dialysis patients: is L-arginine the answer?
Topics: Arginine; Arteriosclerosis; Cardiovascular Diseases; Humans; Models, Biological; Nitric Oxide; Nutrition Disorders; Renal Dialysis | 1994 |
Drugs which modulate nitric oxide homeostasis are likely to provide therapeutic benefit in cardiovascular disease.
Topics: Animals; Arginine; Cardiovascular Diseases; Homeostasis; Humans; Mice; Nitric Oxide; omega-N-Methylarginine; Rats; Shock, Septic; Vasodilation | 1993 |
L-arginine in the clinical arena: tool or remedy?
Topics: Animals; Arginine; Cardiovascular Diseases; Humans | 1993 |
The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin.
Topics: Animals; Arginine; Cardiovascular Diseases; Endotoxins; Enzyme Inhibitors; Hemodynamics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Shock, Septic; Toxemia; Tumor Necrosis Factor-alpha | 1996 |
Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease.
Topics: Acetylcholine; Adult; Arginine; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Endothelium, Vascular; Humans; Insulin; Insulin Resistance; Male; Nitric Acid; Nitric Oxide Synthase; Nitroprusside; Norepinephrine; omega-N-Methylarginine; Plethysmography, Impedance; Vasodilation | 1996 |
Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Arginine; Arteriosclerosis; Autoantibodies; Cardiovascular Diseases; Endothelium, Vascular; Female; Forearm; Humans; Hypercholesterolemia; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Oxidation-Reduction; Phentolamine; Risk Factors; Smoking; Vascular Resistance; Vasodilation; Vasodilator Agents; Vasomotor System | 1996 |
The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.
Topics: Animals; Arginine; beta-Aminoethyl Isothiourea; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Enzyme Induction; Enzyme Inhibitors; Kidney Diseases; Lipopolysaccharides; Male; Multiple Organ Failure; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Wistar | 1995 |
Inducible nitric oxide synthase in the cardiovascular system.
Topics: Animals; Arginine; Cardiovascular Diseases; Cardiovascular System; Endothelium, Vascular; Humans; Macrophages; Nitric Oxide; Nitric Oxide Synthase | 1996 |
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
Topics: Aged; Alleles; Arginine; Aryldialkylphosphatase; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; DNA; Esterases; Female; Gene Expression Regulation; Genetic Linkage; Humans; Leucine; Lipoproteins, HDL; Male; Middle Aged; Odds Ratio; Point Mutation; Polymorphism, Genetic; Risk Factors | 1997 |
Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281-->Arg mutation.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Arginine; Base Sequence; Cardiovascular Diseases; DNA; Female; Genotype; Glutamine; Humans; Japan; Male; Mutagenesis, Site-Directed; Mutation; Phospholipases A; Recombinant Proteins | 1997 |
Dietary arginine and the prevention of cardiovascular diseases.
Topics: Animals; Arginine; Cardiovascular Diseases; Diet; Fatty Acids, Omega-3; Fishes; Humans; Meat; Nitric Oxide; Nuts | 1998 |
Factor V Arg506Gln mutation is not associated with cardiovascular mortality in older women.
Topics: Aged; Arginine; Cardiovascular Diseases; Confidence Intervals; DNA; Factor V; Female; Follow-Up Studies; Genotype; Glutamine; Humans; Middle Aged; Netherlands; Point Mutation; Postmenopause; Prospective Studies; Smoking; Surveys and Questionnaires; Survival Rate | 1999 |
Effect of physical activity on lipid levels in a population-based sample of men with and without the Arg192 variant of the human paraoxonase gene.
Topics: Adult; Aged; Alleles; Arginine; Aryldialkylphosphatase; Cardiovascular Diseases; Cross-Sectional Studies; Esterases; Humans; Isoenzymes; Lipids; Male; Middle Aged; Physical Exertion; Polymorphism, Genetic; Risk Factors | 2000 |
Decreased plasma concentrations of L-hydroxy-arginine as a marker of reduced NO formation in patients with combined cardiovascular risk factors.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Citrulline; Female; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Male; Mass Spectrometry; Middle Aged; Nitric Oxide; Obesity; Risk Factors; Syndrome | 2000 |
Indicators of L-arginine metabolism and cardiovascular risk factors--a cross-sectional study in healthy middle-aged men.
Topics: Adult; Arginine; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Citrulline; Creatinine; Cross-Sectional Studies; Humans; Male; Middle Aged; Orotic Acid; Risk Factors | 2000 |
Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction?
Topics: Animals; Arginine; Biopterins; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Vessels; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Histamine; Humans; Hypercholesterolemia; In Vitro Techniques; Infusions, Intra-Arterial; Ionophores; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Pteridines; Pterins; Reactive Oxygen Species; Species Specificity; Substance P; Swine; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease.
Topics: Adult; Aged; Arginine; Brachial Artery; Cardiovascular Diseases; Clinical Trials as Topic; Dietary Supplements; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Nitric Oxide; Randomized Controlled Trials as Topic; Risk Assessment; Uric Acid; Vasodilation | 2001 |
Effect of homocysteine on the L-arginine/nitric oxide synthase/nitric oxide pathway in human platelets.
Topics: Adult; Arginine; Biomarkers; Blood Platelets; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Nitric Oxide; Nitric Oxide Synthase; Risk Factors | 2002 |
No evidence for an association between genetic polymorphisms of beta(2)- and beta(3)-adrenergic receptor genes with body mass index in Aymara natives from Chile.
Topics: Adult; Altitude; Arginine; Body Mass Index; Cardiovascular Diseases; Chile; Cross-Sectional Studies; Female; Gene Amplification; Gene Frequency; Genotype; Humans; Indians, South American; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Risk Factors; Rural Population; Tryptophan | 2002 |
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Cross-Sectional Studies; Enzyme Inhibitors; Female; Humans; Hypertension; Hypoglycemic Agents; Lipoproteins; Male; Metabolic Diseases; Metabolic Syndrome; Middle Aged; Nitric Oxide Synthase; Regression Analysis; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; Vasodilator Agents | 2002 |
Insulin resistance, ADMA levels, and cardiovascular disease.
Topics: Arginine; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Insulin Resistance; Metabolic Syndrome; Nitric Oxide Synthase; Risk Factors | 2002 |
TAMe esterase activity in human plasma under normal and pathological conditions.
Topics: Arginine; Cardiovascular Diseases; Colorimetry; Diabetes Mellitus; Disease; Esterases; Glomerulonephritis; Hematologic Diseases; Humans; Hyperthyroidism; Leukemia; Neoplasms; Nephrotic Syndrome; Pancreatic Diseases; Skin Diseases; Stomach Neoplasms | 1968 |